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Abstract 
The neural cell adhesion molecule L1, a member of the immunoglobulin 
superfamily, performs important functions in the developing and adult nervous 
system. L1 is implicated in neuronal migration and survival, elongation, 
fasciculation and pathfinding of axons, and synaptic plasticity. Mutations in all 
parts of the L1 gene might cause serious neurological syndromes in humans, 
characterized by increased mortality, mental retardation and various 
malformations of the nervous system. Patients with missense mutations in the 
extracellular domain of L1 often develop severe phenotypes, while mutations in 
the cytoplasmic domain usually cause moderate phenotypes. In an attempt to 
understand the reasons for the frequent occurrence of severe extracellular 
missense mutations, this study addressed the functional consequences of 
extracellular and cytoplasmic L1 mutations.  
To this aim, we used mutated L1 constructs to study their expression in CHO 
cells. The L1 missense mutation C264Y (L1C264Y), located in the extracellular 
domain and causing a severe phenotype in humans, was not expressed at the cell 
surface. Similar results were obtained for a L1 construct with a deletion of the 
putative homophilic binding side (L1∆hbs). In contrast, an intracellularly truncated 
form of L1 showed normal levels of cell surface expression. L1C264Y and L1∆hbs 
protein had a reduced molecular weight due to the lack of Golgi-type modified N-
glycans. These observations suggest that both mutated L1 variants are retained 
within the endoplasmic reticulum (ER). 
To study the expression and the functional consequences of a human pathogenic 
missense mutation in vivo, a transgenic mouse line was generated expressing the 
extracellular missense mutation C264Y under the control of the L1 promoter in a 
L1-deficient background. In these mutant mice, the L1C264Y protein was located 
intracellularly to neuronal cell bodies and displayed an abnormal glycosylation 
state, in line with the results obtained in cell culture experiments. Analysis of the 
L1C264Y transgenic mice revealed no phenotypical differences to L1-deficient 
mice, i.e. both mutants showed reduced survival, a reduced size of the 
corticospinal tract and pathfinding errors of corticospinal axons, and abnormalities 
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of unmyelinated fibers in peripheral nerves. Together, these data indicate that the 
transgenic mice represent functional null mutants.  
We suggest an ER retention followed by degradation of the mutated L1 protein 
as the most likely underlying molecular pathomechanism of the L1C264Y 
missense mutation, ultimately resulting in the loss of L1 function. The combined in 
vitro and in vivo observations corroborate the view that impaired cell surface 
expression of mutated variants of L1 is a potential explanation for the high number 
of severe pathogenic mutations identified within the human L1 gene.  
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Zusammenfassung 
Das neurale Zelladhäsionsmolekül L1 ist ein Mitglied der Immunglobulin 
Superfamilie und erfüllt wichtige Funktionen im sich entwickelnden und adulten 
Nervensystem. So ist L1 an verschiedenen Prozessen, wie der Migration und dem 
Überleben von Neuronen, dem Auswachsen, der Bündelung und der Wegfindung 
von Axonen und der synaptischen Plastizität, beteiligt. Mutationen in allen 
Regionen des L1 Gens können beim Menschen zu gravierenden neurologischen 
Syndromen des sogenannten L1 Spektrums führen. Gemeinsame Merkmale 
dieser Syndrome sind eine erhöhte Sterblichkeit, geistige Behinderung und 
verschiedene Mißbildungen des Gehirns. Patienten mit Punktmutationen in der 
extrazellulären Domäne von L1 entwickeln häufig einen schwereren Phänotyp als 
solche mit Mutationen im zytoplasmatischen Bereich. Um Einblicke in die 
Ursachen für das häufige Auftreten von schwerwiegenden Punktmutationen in der 
extrazellulären Domäne zu gewinnen, wurden in dieser Studie die funktionellen 
Konsequenzen von Mutationen sowohl der extrazellulären als auch der 
intrazellulären Domäne von L1 untersucht. 
Die Expression von mutierten L1 Konstrukten wurde in CHO- (chinese hamster 
ovarian) Zellen analysiert. Es konnte gezeigt werden, daß die pathogene L1 
Punktmutation C264Y (L1C264Y), die in der extrazellulären Domäne liegt und zu 
einem schweren Phänotyp beim Menschen führt, nicht auf der Zelloberfläche 
exprimiert wird. Ähnliche Resultate ergaben sich für ein L1 Konstrukt mit einer 
Deletion der putativen homophilen Bindungsstelle von L1 (L1∆hbs). Im Gegensatz 
dazu zeigte eine intrazellulär deletierte L1-Variante normale L1-Mengen auf der 
Zelloberfläche. Das Molekulargewicht von L1C264Y- und L1∆hbs-Proteinen war 
reduziert, da die N-gekoppelten Oligosaccharide der Proteine keine Golgi-typische 
Modifikationen aufwiesen. Diese Beobachtungen lassen vermuten, daß die 
mutierten Proteine im endoplasmatischen Reticulum (ER) zurückgehalten und 
nicht weiter zum Golgi-Apparat transportiert werden. 
Um die Konsequenzen einer humanpathologischen Mutation auf die Expression 
und Funktion von L1 in vivo zu untersuchen, wurde eine transgene Mauslinie 
erzeugt, in der die extrazellulär gelegene Punktmutation C264Y unter Kontrolle 
des L1-Promotors vor einem L1-defizienten Hintergrund exprimiert wird. In diesen 
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Mausmutanten war das L1C264Y-Protein in neuronalen Zellkörpern lokalisiert und 
wies einen abnormalen Glykosylierungsgrad auf. Diese Ergebnisse stimmen mit 
den Befunden der Zellkultur-Untersuchungen überein. Eine phänotypische 
Analyse der L1C264Y-transgenen Mäuse ergab keine Unterschiede zu L1-
defizienten Mäusen, d.h. beide Mutanten zeigten eine verringerte 
Überlebenswahrscheinlichkeit, eine Reduktion des corticospinalen Traktes, Fehler 
in der Wegfindung von corticospinalen Axonen, sowie abnormale unmyelinisierte 
Fasern in peripheren Nerven. Diese Befunde legen nahe, daß die transgenen 
Mäuse funktionale Null-Mutanten repräsentieren. 
Die Ergebnisse der in vitro und in vivo Untersuchungen deuten darauf hin, daß 
eine Akkumulation des mutierten L1 Proteins im ER, gefolgt von einer Degradation 
des Proteins, den zugrundeliegenden molekularen Pathomechanismus der 
L1C264Y Mutation darstellt. Demnach könnte eine gestörte 
Zelloberflächenexpression ursächlich für das häufige Auftreten von schweren 
pathogenen Punktmutationen im humanen L1 Gen sein. 
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I Introduction 
1 Cell adhesion molecules in the nervous system  
The development of the nervous system depends on a coordinate sequence of 
morphoregulatory processes, such as neural induction, proliferation and 
differentiation of cells, their migration to final destinations, and the patterning of 
neuronal connectivities (Purves and Lichtman, 1983; Goodman and Shatz, 1993; 
Edelman, 1986). In the adult nervous system glial cells and, in certain brain 
regions, also neurons are continuously generated and have to be integrated into 
the existing tissue. In addition, mature neurons have the capacity to change their 
synaptic connectivities and the efficacy of synaptic transmission, a process termed 
synaptic plasticity. A key step in all these processes is the ability of cells and their 
outgrowing axons and dendrites to interact with other cells and the extracellular 
matrix (ECM) (Kater and Rehder, 1995; Gordon-Weeks, 2000). Many of these 
interactions are mediated by a variety of integral membrane proteins, collectively 
termed cell adhesion molecules (CAMs).  
Sequence analysis indicated that many proteins evolved from common 
precursors by duplication and subsequent diversification of genes. Therefore they 
were grouped into families and subfamilies according to their structural similarities 
(Dayhoff et al., 1983). Neural CAMs are divided into three main classes: the Ca2+-
dependent cadherins (more than 40 members; Angst et al., 2001; Tepass et al., 
2000), the heterodimeric integrins (about 17 α- and 8 β-subunits; Clark and 
Brugge, 1995), and the Ca2+-independent molecules of the immunoglobulin (Ig) 
superfamily (for review: Aplin et al., 1998; Juliano, 2002).  
 
2 The immunoglobulin superfamily 
Members of the Ig superfamily of cell recognition molecules are characterized 
by the presence of one or more immunoglobulin modules. Prototypical examples 
of this family are the immunoglobulins themselves (Edelman et al., 1969) and the 
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MHC-antigens (major histocompatibility complex; Orr et al., 1979) of the immune 
system. In contrast to these molecules, which are specialized for highly specific 
antigen recognition, the polypeptide chains constructed by Ig-modules in CAMs 
(Williams and Barclay, 1988) do not form intermolecular, but intramolecular 
disulfide bridges within a module. Most cell recognition molecules in the nervous 
system combine their Ig-like modules with other repeated structures. One of these 
structures is the fibronectin repeat of the subtype III (FNIII domain). This motif was 
originally identified as a repeated module of 90 residues in the ECM molecule 
fibronectin (Kornblihtt et al., 1985) and was later also found in other ECM proteins 
(Engel, 1991). Functional analysis of fibronectin revealed that FNIII domains are 
involved in interactions of cells with the EMC (Ruosalahti and Pierschbacher, 
1987).  
 
N-CAM
L1
F3 DCC
MAG
FGF-R
Transmembrane part
Cytoplasmic domain
Ig-like domain
FNIII domain
Insert specific for 
N-CAM Id isoform
Tyrosine kinase domain
Phosphatidylinositol
linkage
 
Figure 1: Representatives of different subgroups of the immunoglobulin superfamily of cell 
adhesion molecules. Members of the Ig superfamily consist of an extracellular domain with Ig-like 
domains and, in part, fibronectin type III (FNIII) repeats, a single transmembrane region or a GPI 
anchor and, in most cases, an intracellular domain. N-CAM (neural cell adhesion molecule); DCC 
(deleted in colonrectal carcinoma); MAG (myelin-associated glycoprotein); FGF-R (fibroblast 
growth factor receptor). 
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The Ig superfamily is further divided into several subgroups according to the 
number of Ig-domains, the presence and number of FNIII-domains, the mode of 
attachment to the cell membrane, and the presence of a catalytic cytoplasmic 
domain (Fig. 1; Cunningham, 1995). The first isolated and characterized Ig-like 
CAMs were the neural cell adhesion molecule (N-CAM; Brackenbury et al., 1977; 
Thiery et al., 1977) and L1 (Salton et al., 1983; Rathjen and Schachner, 1984), 
representative molecules of two different subgroups. F3 (mouse F3/chicken 
F11/human contactin), DCC (deleted in colonrectal carcinoma, MAG (myelin 
associated glycoprotein), and FGF-R (fibroblast growth factor-receptor) represent 
additional subgroups that occur in the brain (Fig.1)  
 
3 The L1 family 
The L1 family within the Ig superfamily consists of four vertebrate members: L1, 
CHL1 (close homologue of L1), Nr-CAM (Ng-CAM related CAM) and neurofascin, 
and two invertebrate members: neuroglian and tractin (reviewed in Hortsch, 2000; 
Brümmendorf and Rathjen, 1995). All members of the L1 family share a common 
modular structure, composed of six amino-terminal Ig-domains, four to five FNIII-
repeats, a single hydrophobic membrane-spanning region and a short, 
phylogenetically highly conserved cytoplasmic tail at the carboxyl terminus 
(Brümmendorf and Rathjen, 1995). In the developing and adult central nervous 
system (CNS) and peripheral nervous system (PNS) the molecules are involved in 
a variety of morphogenetic processes, including cell migration, axon outgrowth, 
pathfinding and fasciculation, myelination and synaptic plasticity. Members of the 
L1 family are expressed by neurons and glial cells, and are mainly found on the 
surface of axons and at sites of cell-cell contact (Hortsch, 1996).  
 
4 The neural cell adhesion molecule L1 
The neural cell adhesion molecule L1 is one of the most widely studied CAMs 
and closely related L1 homologous were identified in a variety of species, including 
L1CAM (or L1, human), NILE (nerve growth factor-inducible large external 
glycoprotein, rat), L1 (mouse), Ng-CAM (neuron-glia CAM, chick), E587 (goldfish), 
L1.1 and L1.2 (zebrafish), and neuroglian (drosophila). The sequence similarity 
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among species homologous of different animal classes ranges between 30 to 
60X%, with the intracellular domain showing the highest degree of interspecies 
homology (Hortsch, 1996 and 2000). The amino acid sequence of L1 from human 
and mouse, for instance, is 92 % identical, and that between mouse and rat is 
97X% identical. The intracellular domain of L1 from these three species shows 
complete identity. 
 
4.1 Characteristics of L1 
L1 was first described in the mouse CNS as a transmembrane glycoprotein of 
approximately 200 kD. Smaller components of 180, 140, 80, and 50 kD were 
found, and are generated from the 200 kD form by proteolytic cleavage (Lindner et 
al., 1983; Rathjen and Schachner, 1984). Mammalian L1 consists of six Ig-
domains of the C2-type, five FNIII repeats, a single membrane-spanning region 
followed by a short cytoplasmic tail (Fig. 2). 21 putative sites for asparagine-(N-) 
linked glycosylation are distributed over the extracellular domain of L1 (Fig. 2). In 
addition, a substantial portion of the glycans is O-linked as indicated by 
tunicamycin inhibition of cotranslational N-glycosylation (Faissner et al., 1985). 
Glycans contribute about 25 % to the total molecular mass of L1, since 
deglycosylation revealed an apparent molecular mass of about 150 kD (Lindner et 
al., 1983; Rathjen and Schachner, 1984). 
 
 
Figure 2: Structure of L1. The L1 molecule consists of six immunoglobulin domains and five 
complete fibronectin type III repeats next to the N-terminal. The transmembrane region is indicated 
by the yellow box and followed by a short intracellular domain. 21 putative N-glycosylation sites are 
distributed over the extracellular part and indicated by black lollipops.  
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The L1 protein is encoded by a single gene, which is located on the X-
chromosome and contains 29 exons, 28 exons encodes the protein (designated 
1b-28) while one exon contains 5´untranslated sequences (exon 1a) (Kohl et al., 
1992; Kallunki et al., 1997). The mRNA provides an open reading frame of 3783 
nucleotides. The encoded 1260 amino acids comprise a 19 amino acid signal 
peptide and a mature protein of 1241 amino acids (Moos et al., 1988).  
L1 exists as two isoforms that result from alternative splicing. The two isoforms 
are expressed in a tissue- and cell type-specific pattern. Neurons utilize the entire 
28 exon coding sequence of L1 (Takeda et al., 1996). A shorter isoform of L1 
(sL1), exclusively expressed in non-neuronal cells, lacks exon 2 and 27. This form 
was found on cells of hematopoetic origin, in intestinal crypt cells and in the male 
urogenital tract (Kowitz et al., 1992; Thor et al., 1987; Kujat et al., 1995), in the 
epidermis and in the kidney (Nolte et al., 1999; Debiec et al., 1998). More recently 
also oligodendrocytes were found to express sL1 in addition to full-length L1, 
regulated in a maturation-dependent manner (Itoh et al., 2000).  
Differential use of exons 2 and 27 is conserved for L1 orthologous in rodents 
(Jouet et al., 1995a; Miura et al., 1991), teleost fish and fugu (Coutelle et al., 1998) 
suggesting that it is of functional importance. Exon 27 encodes for the four amino 
acids RSLE within the cytoplasmic domain (Fig. 4), which is important as a 
tyrosine-based sorting motif (YRSL) for clathrin-mediated endocytosis (see below) 
(Kamiguchi et al., 1998). Inclusion of exon 2 into the mRNA provides the six amino 
acids YEGHHV in human or YKGHHV in mouse, respectively, in place of a single 
leucine residue immediately amino-terminal to the first Ig-domain (Jouet et al., 
1995 a). 
 
4.2 Expression and function of L1 in the nervous system 
Expression of L1 starts early during neural development, and nerve cells are L1 
immunoreactive as they become postmitotic and start to migrate to their final 
location within the brain. A well-studied example is the L1 positive cells in the inner 
part of the external granule layer of the cerebellum, which resemble mainly 
postmitotic, premigratory granule cells. The outer part of the external granular 
layer which contains proliferating neuroblasts, in contrast, is L1 immunonegative 
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(Lindner et al., 1983; Persohn and Schachner, 1987). After migration, L1 is 
predominantly found on outgrowing and fasciculating axons. In adulthood the 
protein remains expressed on unmyelinated axons, as for example in the 
molecular layers of the cerebellum or the hippocampus, but disappears from 
myelinated axons, i.e. white matter (Bartsch et al., 1989; Martini and Schachner, 
1986). The cellular expression pattern therefore shows a dependancy on the state 
of differentiation. In the PNS, L1 is also expressed by nonmyelinating Schwann 
cells (Martin and Schachner, 1986). 
The cellular expression pattern of L1 is consistent with its functions. During the 
development of the nervous system, L1 plays a role in migration of postmitotic 
neurons (Lindner et al., 1983; Asou et al., 1992), in axon outgrowth, pathfinding 
and fasciculation (Fischer et al., 1986; Lagenaur and Lemmon, 1987; Chang et al., 
1987; Kunz et al., 1996), growth cone morphology (Payne et al., 1992; Burden-
Gulley et al., 1995), adhesion between neurons and between neurons and 
Schwann cells (Rathjen and Schachner, 1984; Faissner et al., 1984; Persohn et 
al., 1987), and in myelination (Seilheimer et al., 1989; Wood et al., 1990 a, b). In 
addition, L1 has been implicated in axonal regeneration (Martini and Schachner, 
1988), learning and memory formation (Rose, 1995), and the establishment of 
long-term potentiation in the hippocampus (Luthi et al., 1994 and 1996). 
 
4.3  Homophilic and heterophilic adhesion 
The variety of L1 functions within the nervous system is probably related to a 
multiplicity of binding partners, potential signaling cascades and posttranslational 
modifications (Fig. 3 and 4). It is generally believed that L1 performs most of its 
functions via homophilic interactions (Miura et al., 1992; Lemmon et al., 1989; 
Hankin and Langenaur, 1994). For instance wild-type neurons extend long 
neurites on purified L1 while neurons from L1 knock-out mice are unable to extend 
processes on purified L1 (Dahme et al., 1997; Fransen et al., 1998). Several 
studies attempted to map the regions that are needed for homophilic binding and 
optimal levels of neurite outgrowth and achieved somewhat different conclusions. 
While some studies (Appel et al., 1993; Holm et al., 1995) found that several 
extracellular domains are required for homophilic interactions, Zhao et al. (1995 
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and 1998) suggested that the second Ig-domain, and more specifically a 14 amino 
acid peptide within this Ig-domain, is sufficient for homophilic binding.  
L1 and its species homologues also interact either in cis or in trans with a 
variety of ligands (Fig. 3), including F3/F11/contactin (Brümmendorf et al., 1993), 
axonin-1/TAG-1 (Kuhn et al., 1991), DM-GRASP (DeBernardo and Chang, 1996), 
laminin (Grumet et al., 1993), and CD24 (or nectradrin; Kadmon et al., 1995; 
Sammar et al., 1997). Furthermore, the Arg-Gly-Asp (RGD) site within Ig-domain 6 
supports binding with subsets of integrins such as α5β1, αVβ1 or αVβ3 (Ruppert et 
al., 1995; Ebeling et al., 1996; Montgomery et al., 1996; Felding-Habermann et al., 
1997).  
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Figure 3: Interactions of the 
extracellular domain of L1 and 
location of all known pathogenic 
missense mutations. The 
distribution of pathogenic missense 
mutations (indicated by gray dots) 
within the extracellular domain of L1 
in relation to the domains involved in 
ligand binding and proteolytic 
cleavage. Broken lines indicate 
different findings in the mapping of 
domains, which are important for 
binding with the indicated partners 
(modified from Kenwrick et al., 
2000).
 
The functional significance of heterophilic L1 interactions is largely unknown. 
However, some of these heterophilic interactions enhance the effects of L1-L1 
interaction. Interactions between L1 and TAG-1/axonin-1 in cis, for instance, are 
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critical in regulating L1-mediated neurite outgrowth (Buchstaller et al., 1996; Rader 
et al., 1996). In addition, some studies suggested a cis interaction of L1 and 
NCAM, which increase homophilic L1 interactions in trans, and thus L1-mediated 
cell aggregation and neurite outgrowth (Kadmon et al., 1990; Simon et al., 1991; 
Horstkorte et al., 1993). An action of both molecules through common pathways, 
but also through different signaling pathways was shown (Williams et al., 1994; 
Takei et al., 1999).  
The findings that neurons from L1-deficient mice fail to respond to the repulsive 
guidance factor semaphorin3A (Sema3A), and that L1 associates with the 
semaphorin receptor neuropilin (Castellani et al., 2000) suggest that L1 serves as 
a co-receptor with neuropilin for Sema3A signal transduction. L1 can also interact 
with the ECM, namely by binding to the chondroitin sulfate proteoglycans 
neurocan and phosphacan, major constituents of the ECM (Rauch et al., 1991 and 
2001; Milev et al., 1994 and 1995). Mapping of the binding site within the first Ig- 
domain of L1 led to the suggestion that binding to neurocan may sterically hinder a 
proper homophilic alignment of L1 (Oleszewski et al., 2000). 
In addition to its cell surface localization, L1 is also released as a soluble 
molecule (Sadoul et al., 1988; Martini and Schachner, 1986; Montgomery et al., 
1996; Beer et al., 1999). L1 shedding results from cleavage near the membrane, 
most likely by a metalloprotease of the ADAM (a distingrin and metalloproteinase) 
family, ADAM 10, and leads to an amino-terminal 180 kD and a membrane 
associated 30 kD fragment (Gutwein et al., 2000; Mechtersheimer et al., 2001). 
This type of L1 cleavage is shown to support integrin-mediated cell adhesion, i.e it 
can stimulate cell migration on fibronectin and laminin by autocrine binding of 
soluble L1 to αvβ5 integrins (Beer et al., 1999; Gutwein et al., 2000; 
Mechtersheimer et al., 2001). Sensitivity to cleavage by the serine protease 
plasmin is found within the third FNIII-like domain of L1, resulting in a soluble 140 
kD and a transmembrane 80 kD fragment (Faissner et al., 1985; Sadoul et al., 
1988; Nyboroe et al., 1990; Kayyem et al., 1992; Burgoon et al., 1995; Nayeem et 
al., 1999). The shedded L1 fragment is suggested to abrogate homophilic L1-L1-
mediated aggregation (Nayeem et al., 1999). 
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4.4 Intracellular events mediated by L1 
Evidence for how CAM interactions might promote axonal growth came from 
studies in which the treatment of neurons with purified CAMs resulted in neurite 
outgrowth and, in parallel, in changes of intracellular pH and Ca2+ levels (Doherty 
and Walsh, 1996). Further, CAM-induced neurite outgrowth was inhibited by 
treatment with pharmacological reagents, including kinase inhibitors or calcium 
channel antagonists (Williams et al., 1992). These results suggested that CAMs 
function by activating second messenger cascades. Indeed, axonal growth in 
response to homophilic L1-L1 interactions in trans seems to be triggered by an 
activation of the FGF-R (a receptor tyrosine kinase) after in cis interactions 
between the extracellular domains of L1 and FGF-R, leading to an 
autophosphorylation of the receptor (Williams et al., 1994 a, b; Doherty et al., 
1996; Doherty and Walsh, 1996; Brittis et al., 1996; Walsh and Doherty, 1997; 
Saffell et al., 1997; Lom et al., 1998; Meiri et al., 1998; Kolkova et al., 2000; Rønn 
et al., 2000). The involved downstream signaling cascade has been worked out in 
detail (activation of PLCγ (phospholipase C) → DAG (diacylglycerine) → via DAG 
lipase: AA (arachidonic acid)) and culminates in transient influx of Ca2+ through L- 
and N-type channels at localized submembrane sites (Archer et al., 1999), 
resulting in a focused signal at a distinct region of the growth cone. How local 
domains of elevated Ca2+ levels subsequently promote growth cone advance is 
not understood, although one possibility might be an action of Ca2+ dependent 
modifiers of the actin cytoskeleton (Doherty et al., 1995).  
Additional signaling cascades following CAM binding have been suggested. L1 
has been shown to be phoshorylated by Cek5 (chicken embryo kinase 5 /EphB2) 
a receptor-type tyrosine kinase of the ephrin (Eph) kinase family (Zisch et al., 
1997; Zisch and Pasquale, 1997), and two serine/threonine protein kinases, 
casein kinase II and p90rsk (Wong et al., 1996 a, b; Kunz et al., 1996). Clustering 
of L1 at the neural surface is reported to transiently activate the MAP kinase 
(mitogen-activated protein kinase) and ERK2 (extracellular signal-regulated 
kinase; Schmid et al., 1999 and 2000). A role of the non-receptor type tyrosine 
kinase src in L1-dependent neurite outgrowth is indicated by the fact that neurite 
outgrowth from src-deficient nerve cells is impaired on an L1 substrate (Ignelzi et 
al., 1994). An example for influences of heterophilic binding on such signaling 
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cascades is the finding that dimerization of L1 with TAG1/axonin-1 is associated 
with non-receptor tyrosine kinase activation (Kunz et al., 1996). 
The most conserved feature among all members of the L1-subgroup is their 
ability to interact with the spectrin-based membrane skeleton by binding to the 
adaptor protein ankyrin (Davis and Bennett, 1993 und 1994; Hortsch, 2000). The 
ankyrin binding motif FIGQY within the cytoplasmic tail of L1 is highly conserved, 
and phosphorylation of the tyrosine within this sequence abolishes association 
with ankyrin (Garver et al., 1997; Zhang et al., 1998; Hortsch et al., 1998). 
Interactions between L1 and ankyrin might be a mechanism by which interactions 
with the substrate are linked to the cytoskeleton and lead to ankyrin-dependent 
alterations in the cellular organization or in the targeting of proteins to specific 
membrane compartments (for review: Bennett and Chen, 2001). Interestingly, one 
human pathological missense mutation within the ankyrin binding side of L1 
(substitution of tyrosine to histidine; Y1229H) results in an abolishment of both 
ankyrin-binding activity and phospho-tyrosine signaling, indicating a regulation of 
ankyrin binding via phosphorylation of the tyrosine within the binding site 
(Kenwrick et al., 2000). Finally, ankyrin-B knock-out mice exhibit a phenotype 
similar to L1 knock-out mice, and share features of human patients with L1 
mutations (Scotland et al., 1998). 
L1 has also been shown to colocalize with filamentous actin in the filopodia and 
lamellipodia of growth cones of cultured chick dorsal root ganglion neurons 
(Letourneau and Shattuck, 1989) and to bind indirectly to actin (Gumbiner, 1993). 
The sequence motif crucial for binding to actin stress fibers is close to the serine 
residue phosphorylated by p90rsk, suggesting a link of L1-mediated neurite 
outgrowth with binding to the actin-based cytoskeleton (Dahlin-Huppe et al., 
1997). 
Recent studies gave insights into the molecular mechanisms by which L1 might 
be functionally involved in growth cone migration. Clathrin-mediated endocytosis 
of L1 occurs preferentially in the central domain of growth cones followed by 
centrifugal transport of vesicles into the peripheral domains and reinsertion into 
the membrane at the leading edge (Kamiguchi et al., 1998; Kamiguchi and 
Lemmon, 2000; Kamiguchi and Yoshihara, 2001). This system may be 
responsible for producing polarized adhesion and directed migration of the growth 
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cone. Critical for the clathrin-mediated endocytosis is an interaction of the 
tyrosine-based motif YRSL (YXXΦ; X is any aa; Φ is an aa with a hydrophobic 
bulk chain) within the cytoplasmic domain of L1 with the µ2 chain of the clathrin-
adaptor AP-2 (Kamiguchi et al., 1998; Kamiguchi and Lemmon 1998). This 
interaction may then result in a concentration of L1 in clathrin-coated areas of the 
plasma membrane. Interestingly, the YRSL motif contains the alternatively spliced 
RSLE sequence, which is absent from L1 of non-neuronal cells (Kamiguchi and 
Yoshihara, 2001). 
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Figure 4: Binding and 
phosphorylation sites within 
the intracellular domain of 
L1 in relation to the location 
of all known pathogenic 
mutations. Gray boxes 
indicate binding or alternative 
splice sites. Missensense 
mutations, which affect 
phoshorylation sites, are 
shown in open boxes 
(modified from Kenwrick et al., 
2000). 
 
4.5 Mutations in the L1 gene cause severe neurological 
disorders in humans 
In 1990, the human gene encoding L1 has been located near the long arm of 
the X-chromosome (Djabali et al., 1990) in Xq28 (Chapman et al., 1990). Since 
different X-linked mental retardation syndromes have already been located to 
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Xq28 and the morphological abnormalities of these syndromes might result from 
deficits in cell migration, axonal pathfinding and fasciculation, L1 was a likely 
candidate gene causing these syndromes. HSAS syndrome (hydrocephalus due to 
stenosis of the aqueduct of Sylvius; Bickers and Adams, 1949) was first attributed 
to mutations in the L1 gene (Rosenthal et al., 1992). Subsequently, L1 mutations 
were found in patients with MASA syndrome (mental retardation, aphasia, 
shuffling gait and adducted thumbs; Bianchine and Lewis, 1974), X-linked 
complicated SP-1 (spastic paraplegia; Kenwrick et al., 1986) or ACC (agenesis of 
the corpus callosum; Kaplan et al., 1983) (Jouet et al., 1994; Fransen et al., 1994; 
Vits et al., 1994). The fact that all of these conditions are allelic disorders proved 
that HSAS, MASA, SP-1, and ACC represent overlapping clinical spectra of the 
same disease, and are therefore now summarized under the term ´L1 spectrum` 
(Moya et al., 2002). This term might be more widely acceptable than the previously 
proposed term CRASH (corpus callosum agenesis, retardation, adducted thumbs, 
shuffling gait, and hydrocephalus, Fransen et al., 1995).  
L1 mutations account for 5 % of all cases with hydrocephalus and are the most 
frequent genetic cause of this pathology. The incidence of pathological L1 
mutations is generally estimated to be around 1 in 30,000 male births (Halliday et 
al., 1986; Schrander-Stumpel and Fryns, 1998). In general, the patients show a 
broad spectrum of clinical and neurological abnormalities, already reflected by the 
varying nomenclature. The severity of the disease varies significantly between 
patients with different L1 mutations and might also vary between patients carrying 
the same mutation (Serville et al., 1992). The most consistent features of affected 
patients are varying degrees of lower limb spasticity, mental retardation with IQs 
ranging between 20 and 50, enlarged ventricles or hydrocephalus (Fig. 5 B-D), 
and flexion deformities of the thumbs (Fig. 5 A). Those that develop hydrocephalus 
in utero or soon after birth have a low life expectancy and many of them die 
neonatally. Another striking morphological abnormality is a hypoplasia of the 
corticospinal tract (CST; compare Fig. 5 E and F) and the corpus callosum (Fig. 5 
B-D). The CST is important for voluntary motor functions and its impaired 
development in affected patients might therefore be responsible for the spasticity. 
The corpus callosum connects the cerebral hemispheres and pathological 
alterations of this large commissure might contribute to mental retardation. Other 
brain malformations include hypoplasia of the septum pellucidum and the 
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cerebellar vermis, and fusion of the thalami and colliculi (Fig. 5; for review see: 
Wong et al., 1995b; Fransen et al., 1996 and 1997; Kenwrick et al., 2000). 
 
 
Figure 5: Patients with 
syndromes of the L1 spectrum. 
A: Adducted thumb of an affected 
newborn patient. B: MRI scan 
(magnetic resonance image) of 
the head of same newborn as in 
(A), showing massive hydro-
cephalus. C and D: MRI scan of 
the head of a 5 year old affected 
child showing dysgenesis of the 
corpus callosum and dilated 
lateral ventricles. E and F: The 
corticospinal tract of an affected 
patient (arrow in F) is significantly 
reduced in size when compared to 
the tract of a healthy individual 
(CST in E). (A and B: from 
Schrander-Stumpel and Fryns, 
1998; C and D from Moya et al., 
2002; E and F: from Wong et al., 
1995b). 
 
 
4.6 Genotype-phenotype relationship for L1 mutations 
Up to date, about 140 different pathogenic mutations have been identified in 
virtually all regions of the gene. Hot spots for pathogenic mutations have not been 
observed. The majority of mutations are restricted to single families (for a 
continuously updated list of L1 mutations, see the L1 mutation web page 
http://dnalab-www.uia.ac.be/dnalab/l1/; Van Camp et al., 1996). All kinds of 
mutations were found in human patients including missense, nonsense, and frame 
shift mutations, deletions, insertion, and splice site mutations with often unknown 
consequences for the amino acid sequence. Despite the wide range of symptoms, 
a certain correlation between the severity of the disease and the type and location 
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of the mutation has been demonstrated (Bateman et al., 1996; Fransen et al., 
1998 b; Michaelis et al., 1998; Yamasaki et al., 1997). Patients carrying known L1 
mutations were scored as being ´severely` or ´mildly` affected. Severely affected 
patients either died before the age of 2 years, were born macrocephalic, or 
needed shunt. Mildly affected patients had none of these three criteria. 
Mutations that truncate the protein in the extracellular domain are expected to 
abolish cell surface expression and therefore to result in a ´loss of function` of L1-
mediated interactions. Such truncations generally produce the most severe 
phenotypes (Yamasaki et al., 1997). Most frequent are missense mutations within 
the extracellular domain (35%), which in many cases cause a severe phenotype 
but might also result in a relatively mild phenotype. An explanation for the variable 
outcome of missense mutations came from computer modeling studies, which 
classified extracellular missense mutations into ´key` and ´surface` amino acid 
residues. Key residues are responsible for maintaining the conformation of L1 in 
its respective domains, whereas surface residues are expected to have little 
influence on the rest of the domain, but might be important for the finely tuned 
interactions of L1 with its various ligands (Bateman et al., 1996). Indeed, 
substitutions involving the ‘key’ residues produce the most severe forms of 
hydrocephalus and are most deleterious to infant survival (Michaelis et al., 1998; 
Fransen et al., 1998b). However, the reasons for the high number of different L1 
missense mutations with severe consequences remain only partly understood, 
and appropriate animal models for such conditions are still missing. Potentially, 
these mutations might interfere with homophilic or heterophilic interactions of L1 or 
with the targeting of the protein to the cell surface (De Angelis et al., 1999 and 
2002; Moulding et al., 2000).  
In contrast, any kind of mutation within the cytoplasmic domain cause moderate 
or variable phenotypes with rare observations of severe hydrocephalus, grave 
mental retardation or death before the second postnatal year. These mutations are 
expected to interfere with intracellular signaling and interactions with the 
cytoskeleton, but are unlikely to disrupt L1-mediated adhesion as indicated by the 
observations that a deletion of large portions of the intracellular domain of L1 
(Wong et al., 1995 a) or Drosophila neuroglian (Hortsch et al., 1995) did not affect 
L1-dependent homophilic cell-cell interactions.  
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4.7 The L1-deficient mouse: an animal model for human 
diseases of the L1 spectrum 
To obtain a mouse model for L1 spectrum, two mouse L1 knock-out (L1ko) lines 
were independently generated in two laboratories by targeted disruption of the L1 
gene (Dahme et al., 1997; Cohen et al., 1998). Many of the pathological features 
observed in human patients with L1 mutations were also seen in these L1ko mice, 
and their analysis provided important insights into the functions performed by L1 in 
vivo (Dahme et al., 1997; Cohen et al., 1998; Fransen et al., 1998 a; Demyanenko 
et al., 1999; Haney et al., 1999; Rolf et al., 2001). The phenotypes of the two 
independently generated L1 mutants showed many similarities. The body size of 
both mutants was significantly reduced when compared with wild-type littermates, 
the eyes were lacrimous and further back in their sockets and thus appeared 
smaller, and both mutants showed difficulties to use their hind legs (Cohen et al., 
1998; Dahme et al., 1997). The latter observation may parallel the shuffling gait of 
patients with L1 spectrum. L1 mutant mice also showed a decreased sensitivity to 
touch and pain (Dahme et al., 1997). Although a few L1 mutants were able to 
breed, the vast majority of them were sterile (Cohen et al., 1998; our unpublished 
observations). The mortality of the mutants was increased when bred in a 129Sv 
mouse strain background and, even more, in a C57 genetic background. The 
higher mortality in the C57 strain correlated with a more severe phenotype when 
compared to mutants with a 129-background (see below). L1 mutants and wild-
type mice were subjected to a passive avoidance-learning task, and both 
genotypes showed a similar learning ability (Fransen et al., 1998a). However, 
experiments in the Morris water maze revealed impaired spatial learning of L1 
mutants compared to wild-type controls (Fransen et al., 1998a). 
The L1ko mice showed diverse morphological abnormalities. The CST of L1-
deficient mice was reduced in size by about 40 % (Dahme et al., 1997). The 
hypoplasia of the CST was shown to result from pathfinding errors of corticospinal 
axons (Cohen et al., 1998). In wild-type mice, the majority of these axons turns 
dorsally at the pyramidal decussation, located at the caudal end of the medulla 
oblongata, and extends into the contralateral dorsal column. In L1-deficient mice, 
however, the majority of axons stayed ventrally and entered the contralateral 
pyramid or turned dorsally, but entered the ipsilatral instead of the contralateral 
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dorsal column (Cohen et al., 1998). The abnormalities of the corticospinal tract 
might explain the locomotor deficits of L1 mutants and also of patients with L1 
spectrum.  
Significant hypoplasia was also reported for the corpus callosum, the major 
commissure of the brain (Demyanenko et al., 1999). This defect apparently 
resulted from a failure of callosal axons to cross the midline of the brain and is 
also found in patients with L1 spectrum. Other abnormalities of L1 mutants 
reported in the same study included abnormal morphology of septal nuclei, an 
approximately 30 % reduction in the number of hippocampal pyramidal and 
granule cells, and an abnormal orientation and undulating appearance of apical 
dendrites of a fraction of pyramidal cells in motor, visual, and somatosensory 
cortices (Demyanenko et al., 1999).  
Given that anti-L1 antibodies interfere with the migration of granule cells in 
cerebellar explant cultures and with the elongation and fasciculation of neurites of 
cerebellar nerve cells, it is remarkable that the cytoarchitecture of the cerebellar 
cortex of L1 mutants showed no evidence for disturbed cell migration, axon 
outgrowth, or axon fasciculation (Dahme et al., 1997). The only abnormality 
reported for the cerebellum of L1 mutants was a hypoplasia of the cerebellar 
vermis (Fransen et al., 1998 a), a defect also frequently observed in patients with 
L1 spectrum (Yamasaki et al., 1995). In addition to the unexpectedly mildly 
affected cerebellum, axon tracts other than the CST and the corpus callosum 
appear to develop normal in L1-mutant mice (Cohen et al., 1998; Dahme et al., 
1997). One explanation might be that other molecules, which perform similar 
functions as L1, might compensate for the lack of L1 and thus allow normal 
development of the cerebellum and of the majority of axon tracts in the mutant.  
The most striking defect of L1 mutant mice is certainly the significant 
enlargement of the ventricular system (hydrocephalus). This abnormality is again 
reminiscent of pathological alterations reported for brains of patients with L1 
spectrum. Massively enlarged lateral ventricles were observed in L1 mutants with 
a C57 genetic background, whereas only slightly ventricular dilations were found 
in mutants with a 129 background (Dahme et al., 1997; Fransen et al., 1998 a; 
Demyanenko et al., 1999). The strong dependence of this defect on the genetic 
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background suggests that modifier genes, together with the mutated L1 gene, 
determine the severity of this morphological abnormality.  
In the PNS, where nonmyelinating Schwann cells express sL1, L1 deficient 
mice show defects in unmyelinated fibers. These morphological abnormalities 
include a reduced number of unmyelinated axons per nonmyelinating Schwann 
cell, Schwann cell processes extending into the endoneurial space, and the 
presence of incompletely ensheathed unmyelinated axons (Dahme et al., 1997; 
Haney et al., 1999). These defects demonstrate that L1 is essential for normal 
interactions between nerve cells and nonmyelinating Schwann cells and probably 
also for the long-term maintenance of unmyelinated axons. 
 
5 The aim of this study 
As discussed above, pathogenic missense mutations within the extracellular 
domain might cause severe phenotypes, but might also result in a relatively mild 
phenotype. Compared to the phenotypic variability of extracellular mutations, any 
kind of mutation within the intracellular domain causes relatively mild phenotypes. 
The latter fact is remarkable with regard to the high degree of conservation of the 
cytoplasmic domain, which is generally considered as a hint for functional 
importance. Thus, for missense mutations or short in frame deletions and 
insertions, the disease-causing nature of the mutation is not directly evident and, 
despite same in vitro studies on L1 missense mutations, only partly understood. 
To obtain insights into consequences of L1 mutations concerning hetero- or 
homophilic interactions, posttranslational processing or protein trafficking, we 
addressed a detailed characterization of different L1 mutations in vitro: The 
following mutations were analyzed: 
1.  The pathogenic L1 missense mutation C264Y within the third Ig domain is 
known to cause a severe syndrome in humans, called HSAS (Jouet et al., 
1993).  
2. The putative 14 amino acid homophilic binding site within the second Ig  
domain (Zhao et al., 1998) was chosen for deletion. This sequence contains 
three pathogenic missense mutations: I179S, R184W and R184Q (Ruiz et al., 
1995; Fransen et al., 1996; Jouet et al., 1994).  
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3. Intracellularly truncated L1 was studied to obtain insights into the functional 
consequences of pathogenic mutations within the intracellular domain. 
4.  Short L1 variants with deletion of exon 2 and/or exon 27 were included, in 
which the extra- and/or the intracellular domain is affected. Deletion of exon 2 
possibly mimics a pathogenic mutation within the donor splice site located in 
intron 1 which is predicted to result in skipping of exon 2 (Jouet et al., 1995; 
Jouet and Kenwrick, 1995). 
 
The L1-deficient mouse displays many of the pathological features of patients 
with L1 mutations. However, in humans the majority of pathogenic L1 mutations 
have been identified as small deletions or insertions and missense mutations 
rather than null mutations. Since many of these mutations might affect only single 
L1 functions or lead to gain of functions, the question of how these mutations 
affect the development of the nervous system cannot be answered by the analysis 
of the L1-deficient mouse. Therefore, we generated and analyzed a transgenic 
mouse line, which expresses the human pathogenic L1C264Y missense mutation 
under the control of the L1 promoter in a L1-deficient background. 
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II Materials and Methods 
1 Materials 
1.1 Chemicals 
All chemicals were obtained from the following companies in p.a. quality: 
GibcoBRL (Life Technologies, Karlsruhe, Germany), Macherey-Nagel (Düren, 
Germany), Merck (Darmstadt, Germany), Serva (Heidelberg, Germany) and 
Sigma-Aldrich (Deisenhofen, Germany). 
Restriction enzymes were obtained from New England biolabs (Frankfurt am Main, 
Germany) and MBI Fermentas (St. Leon-Rot, Germany), molecular weight 
standards were obtained from GibcoBRL. DNA purification kits were purchased 
from Life Technologies, Pharmacia Biotech (Freiburg, Germany), Macherey & 
Nagel and Qiagen (Hilden, Germany). Plasmids and molecular cloning reagents 
were obtained from Clontech, Invitrogen, Pharmacia Biotech, Promega, Qiagen 
and Stratagene. Oligonucleotides were ordered from metabion (Munich, 
Germany). All oligonucleotides used are listed in the appendix. Cell culture 
material was ordered from Nunc or Life Technologies. 
 
1.2 Solutions and buffers 
(in alphabetical order) 
Blotting buffer, pH 8.3 25 mM Tris-HCl 
(Western Blot) 190 mM Glycin 
 0.01 % SDS 
 10 % Methanol 
Boston buffer 50 mM Tris-HCl, pH 8.0 
(Lysis of tail cuts) 50 mM KCl 
 2.5 mM EDTA 
 0.45 % NP-40 
 0.45 % Tween 20 
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Citrate buffer (2x) 75 mM Sodium citrate, pH 5.5 
(Endo H digestion) 
CompleteTM (25x) Protease-inhibitors pills; 1 tablet resuspended in 2 ml 
solution results in a 25xstock solution 
Denhardts (50x) 1 % BSA 
(Southern Blotting) 1 % Ficoll 
 1 %  polyvinylpyrolidon 
DNA-sample buffer (5x) 20 % (w/v) glycerol in TAE buffer 
(DNA-gels) 0,025 % (w/v) orange G or bromophenol blue 
dNTP-stock solutions 25 mM each dATP, dCTP, dGTP, dTTP 
(PCR) 
Ethidiumbromide- 10 µg/ml ethidiumbromide in 1xTAE 
staining solution (DNA-gels) 
Lysis buffer I 20 mM  Tris-HCl, pH 7.5 
(lysis of brain) 150 mM NaCl 
 1 mM EDTA 
 1 mM EGTA 
  1 x completeTM (directly before use)  
Lysis buffer II 20 mM  Tris-HCl, pH 7.5 
(lysis of brain) 150 mM NaCl 
 1 mM EDTA 
 1 mM EGTA 
 1 % (w/v) NP-40 
  1 x completeTM (directly before use)  
MOPS (10x) 220 mM  MOPS, pH 7.4 
(PBS-CM) 50 mM  Na-acetate 
 10 mM EDTA 
  
Phosphate buffered saline  
(PBS, biochemistry) 150 mM  NaCl 
 8.1 mM  Na2HPO4,  
 1.7 mM NaH2PO4  pH 7.4 
(PBS, morphology) 270 mM NaCl 
 19 mM  Na2HPO4 
 5 mM KCl 
 3.4 mM KH2PO4   pH 7.4 
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PBS with Ca2+, Mg2+ 150 mM  NaCl  
(PBS-CM) 20 mM  Na3PO4, pH 7.4 
 0.2 mM  CaCl2 
 2 mM MgCl2 
RIPA-buffer  50 mM  Tris-HCl, pH 7.4 
(cell lysis) 150 mM NaCl 
 1 % (w/v)  NP-40 
1 mM  EDTA 
1x completeTM proteinase inhibitor cocktail 
Running Gel 8.0 % 4.89 ml  deionized water 
(protein gels) 5.26 ml   1 M Tris-HCl, pH 8.8 
0.14 ml  10 % SDS 
3.73 ml  30 % Acrylamide – Bis 29:1 
70.0 µl  10 % APS 
7.00 µl  TEMED 
SDS sample buffer (5x) 62.5 mM  Tris-HCl, pH 6.8 
(protein gels) 2 % (w/v) SDS 
 5 % (w/v) β-mercaptoethanol 
 20 % (v/v) Glycerol 
 0.04 % (w/v) bromphenolblue 
SDS running buffer (10x) 0.25 M Tris-HCl 
(protein gels) 1.90 M glycine 
 1 % (w/v) SDS 
 10 % methanol, pH 8.3 
SSC (20x) 3 M NaCl 
 0.3 M  Na3-citrate, pH 7.5 
SSPE (20x) 3.6 M NaCl 
 0.2 M sodium phosphate 
 0.02 M EDTA, pH 7.7 
Stacking Gel 5 % 3.77 ml  deionized water 
(protein gels) 0.32 ml   1 M Tris-HCl, pH 6.8 
0.05 ml   10 % SDS 
0.83 ml   30 % Acrylamide – Bis 29:1 
25.0 µl 10 % APS 
7.00 µl  TEMED 
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Stripping buffer 0.5 M NaCl 
(Western blots) 0.5 M acetic acid 
TAE (50x) 2 M Tris-Acetat, pH 8,0 
(DNA-gels) 100 mM EDTA 
TE (10x) 0,1 M Tris-HCl, pH 8.0 
 10 mM EDTA 
 
1.3 Bacterial and cell culture media 
Bacterial media were autoclaved and antibiotics were supplemented prior to use. 
Cell culture media were prepared from a 10x stock solution purchased from Gibco 
GBL and were sterile filtered. 
DMEM (for TE761 cells) Dulbecco MEM, high glucose (4500 mg/l) 
 supplemented with  
 5 % (v/v) fetal calf serum (FCS) 
 1x non-essential amino acids 
 50 U/ml penicilline/streptomycine (P/S) 
 1 mM pyruvate 
 4 mM L-glutamine 
GMEM (for CHO cells) Glasgow MEM (with nucleotides; L-glutamine) 
 supplemented with  
 10 % (v/v) fetal calf serum (FCS) 
 1x non-essential amino acids 
 50 U/ml penicilline/streptomycine 
 1 mM pyruvate 
 4 mM L-glutamine 
LB-agar 20 g/l  agar LB-medium 
LB-medium 10 g/l bacto-tryptone   
 10 g/l NaCl 
 5 g/l  yeast extract, pH 7.4  
Antibiotic- and X-Gal- 150 mg/l ampicillin (Amp) 
concentrations 50 mg/l chloramphenicol (Cm) 
(in medium or agar) 25 mg/l kanamycin (Kan) 
 25 mg/l X-Gal 
Versene Gibco GBL  
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1.4 Bacterial strains and cell lines 
CHO-K1 Chinese Hamster Ovary 
TE671 human fibroblast cell line  
Escherichia coli DH5α  F¯, supE44, DlacU169, [Φ80lacZDM15], hsdR17, 
recA1, endA1, gyrA96, thi-1, relA1, (res¯, mod+), deoR;  
NEB 
Escherichia coli XL1-Blue recA1, end A1, gyrA96, thi-1, hsdR17, supE44, relA1,  
 lac[F’proAB laclqZ∆M15Tn10(Tetr)]; Stratagene 
 
1.5 Plasmids 
pBlueCm SK (+) cloning vector; lacZα;  Cm-resistance (r) (Stratagene) 
pcDNA3 mammalian expression vector; Amp-r (Invitrogen) 
pCRuni-3.1uni mammalian expression vector; Amp-r (Stratagene) 
pK19 pUC19, replacement of Ampr- to Km-r, lacZα; (Pridmore, 1987) 
pGEM2 cloning vector; Amp-resistance (Promega) 
 
1.6 Antibodies 
1.6.1 Primary antibodies 
mc-αL1-555 monoclonal rat anti-mouse L1 antibody, supernatant of 
rat hybridoma cell line (produced in the lab of M. 
Schachner; Appel et al., 1995) 
immunoblot:    1:8 in 2 % M-PBS 
immunocytochemistry:  undiluted. 
pc-αL1-a: polyclonal rabbit anti-mouse L1 antibody, purified blood 
serum (Dr. F. Plöger, ZMNH) 
 Immunoblot:     1:8000 in 2 % M-PBS 
pc-αL1-b polyclonal rabbit anti-mouse L1 antibody, purified rabbit 
blood serum (Fraissner et al., 1985) 
 Immunohistochemistry:  1:500 in PBS 
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1.6.2 Secondary antibodies 
All horseradish-coupled secondary antibodies were purchased from dianova and 
used for immunoblot analysis in a dilution of 1:10,000.  
For immunocytochemistry and -histochemistry, Cy3, and FITC -labeled secondary 
antibodies were obtained from dianova and used in a dilution of 1:500. 
 
 
2 Methods   
2.1 Molecular biological methods 
2.1.1 Maintenance of bacterial strains 
(Sambrook et al., 1989) 
Strains were stored as glycerol stocks (LB-medium, 25 % (v/v) glycerol) at –70°C.  
An aliquot of the stock was streaked on an LB-plate containing the appropriate 
antibiotics and incubated overnight at 37°C. Plates were stored for up to 6 weeks 
at 4°C.  
 
2.1.2 Production of competent bacteria  
(Inoue et al., 1990) 
DH5α bacteria were streaked on LB-plates and grown overnight at 37°C. 50 ml of 
LB-medium was inoculated with 5 colonies and grown at 37°C until the culture had 
reached an optical density (OD600) of 0.3-0.5. Cells were pelleted at 3,000 rpm and 
4°C and resuspended in 30 ml cold TFBI-buffer (30 mM KAc, 50 mM MnCl2 4 H20, 
100 mM RbCl, 10 mM CaCl2, 15 % glycin, adjusted to pH 5.8 with 0.2 N acetic 
acid, ad to 500 ml with ddH20 and sterile filtered). After incubation for 10 min on 
ice, cells were pelleted at 3,000 rpm and 4°C for 10 min and resuspended in 4 ml 
TFBII-buffer (10 mM MOPS, 75 mM CaCl2, 10 mM RbCl, 15 % glycin, adjusted to 
pH 5.8 with 0.2 N acetic acid, ad to 500 ml with ddH20 and sterile filtered). Aliquots 
of 100 µl were stored at –80°C. 
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2.1.3 Transformation of bacteria 
(Sambrook et al., 1989) 
To 100 µl of competent DH5α either 50-100 ng of plasmid DNA or 20 µl of ligation 
mixture were added and incubated for 30 min on ice. After a heat shock (2 min, 
42°C) and successive incubation on ice (3 min), 800 µl of LB-medium were added 
to the bacteria and incubated at 37°C for 30 min. Cells were then centrifuged 
(10,000 x g, 1 min, RT) and the supernatant removed. Cells were resuspended in 
100 µl LB medium and plated on LB plates containing the appropriate antibiotics. 
Plates were incubated at 37°C overnight. 
 
2.1.4 Plasmid isolation of E. coli  
2.1.4.1 Plasmid isolation from 3 ml cultures (Minipreps) 
(Sambrook et al., 1989; Amersham Pharmacia Mini preparation kit) 
3 ml LB/Amp- or /Cm-medium were inoculated with a single colony and incubated 
over night at 37°C with constant agitation. Cultures were transferred into 2 ml 
Eppendorf tubes and cells were pelleted by centrifugation (12,000 rpm, 1 min, RT). 
Plasmids were isolated from the bacteria according to the manufactures protocol. 
The DNA was eluted from the columns by addition of 50 µl Tris-HCl (10 mM, pH 
8.0) with subsequent centrifugation (12,000 rpm, 2 min, RT).  
 
2.1.4.2 Plasmid isolation from 15 ml-cultures 
(Macherey-Nagel Nucleospin kit) 
To obtain rapidly higher amounts of DNA, the Macherey-Nagel Nucleospin kit was 
used. 15 ml LB/Amp- or /Cm-medium were inoculated with a single colony and 
incubated over night at 37°C with constant agitation. Cultures were transferred into 
15 ml Falcon tubes and cells were pelleted by centrifugation (12,000 rpm, 1 min, 
RT) in a eppendorf centrifuge. Plasmids were isolated from the bacteria according 
to the manufactures protocol with the exception that twice the suggested amount 
of buffers were used. DNA was eluted from the columns by adding twice 50 µl of 
prewarmed (65°C) Tris-HCl (10 mM, pH 8.0) with subsequent centrifugation 
(12,000 rpm, 2 min, RT). Finally, the concentration was determined. 
 
II Materials and Methods   30 
2.1.4.3 Plasmid isolation from 500 ml-cultures (Maxipreps) 
(Quiagen Maxiprep kit) 
For preparation of large quantities of DNA, the Qiagen Maxiprep kit was used. A 
single colony was inoculated in 2 ml LB/Amp- or /Cm- medium and grown at 37°C 
for 8 h with constant agitation. Afterwards, this culture was added to 500 ml 
LB/amp- or /Cm- medium and the culture was incubated at 37°C with constant 
agitation overnight. Cells were pelleted in a Beckmann centrifuge (6,000 x g, 15 
min, 4°C) and DNA was isolated as described in the manufactures protocol. 
Finally, the DNA pellet was resuspended in 600 µl of prewarmed (70°C) Tris-HCl 
(10 mM, pH 8.0) and the DNA concentration was determined. 
 
2.1.5 Enzymatic modification of DNA 
2.1.5.1 Digestion of DNA 
(Sambrook et al., 1989) 
For restriction, the DNA was incubated with twice the recommended amount of 
appropriate enzymes in the recommended buffer for 2 h. If two enzymes were 
incompatible with each other, the DNA was digested successively with the 
enzymes. The DNA was purified between the two digestions using the rapid 
purification kit (Life technologies). Restriction was terminated by addition of 
sample buffer and applied on a agarose gel. 
 
2.1.5.2 Dephosphorylation of Plasmid-DNA 
(Sambrook et al., 1989) 
After restriction, the plasmid DNA was purified and SAP buffer (Boehringer 
Ingelheim) and 1 U SAP (scrimps alkaline phosphatase) per 100 ng plasmid DNA 
was added. The reaction was incubated at 37°C for 2 h and terminated by 
incubation at 70°C for 10 min. The plasmid DNA was used for ligation without 
further purification. 
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2.1.5.3 Ligation of DNA-fragments 
(Sambrook et al., 1989) 
Ligation of DNA fragments was performed by mixing 50 ng vector DNA with the 
fivefold molar excess of insert DNA. 1 µl of T4-ligase and 2 µl of ligation buffer 
(both Boehringer Ingelheim) were added and the reaction mix was brought to a 
final volume of 20 µl. The reaction was incubated either for 2 h at room 
temperature or overnight at 16°C. The reaction mixture was used directly for 
transformation without any further purification. 
 
2.1.6 DNA Gel-electrophoresis 
(Sambrook et al., 1989) 
DNA fragments were separated by horizontal electrophoresis chambers (BioRad) 
using agarose gels. Agarose gels were prepared by heating 1-2.5 % (w/v) agarose 
(Gibco) in 1xTAE buffer, depending on the size of DNA fragments. The gel was 
covered with 1xTAE buffer and the DNA samples were pipetted in the sample 
pockets. DNA sample buffer was added to the probes and the gel was run at 
constant voltage (10 V/cm gel length). Afterwards, the gel was stained in an 
ethidiumbromide staining solution for 20 min. Finally gels were documented using 
a UV-light imaging system. 
 
2.1.7 Extraction of DNA fragments from agarose gels 
(Rapid gel extraction kit, Life technologies) 
For isolation and purification of DNA fragments from agarose gels, 
ethidiumbromide-stained gels were illuminated with UV-light and the appropriate 
DNA band was excised from the gel with a clean scalpel and transferred into an 
Eppendorf tube. The fragment was isolated following the manufactures protocol. 
The fragment was eluted from the column by addition of 50 µl prewarmed (70°C) 
Tris-HCl (10 mM, pH 8.0). The DNA-concentration was determined using the 
undiluted eluate.  
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2.1.8 Purification of DNA fragments 
(Rapid PCR Purification kit, Life technologies) 
For purification of DNA fragments the Rapid PCR Purification kit was used 
according to the manufactures protocol. The DNA was eluted from the column by 
addition of 50 µl prewarmed (70°C) Tris-HCl (10 mM, pH 8.0). The DNA-
concentration was determined using the undiluted eluate.  
 
2.1.9 Determination of DNA concentrations 
DNA concentrations were determined spectroscopically using an Amersham-
Pharmacia spectrometer. The absolute volume necessary for measurement was 
50 µl. For determining the concentration of DNA preparations, the eluate was 
diluted 1:50 with water and the solution was pipetted into a 50 µl cuvette. 
Concentration was determined by measuring the absorbance at 260 nm, 280 nm 
and 320 nm. Absorbance at 260 nm had to be higher than 0.1 but less than 0.6 for 
reliable determinations. A ratio of A260/A280 between 1,8 and 2 monitored a 
sufficient purity of the DNA preparation.  
 
2.1.10 DNA Sequencing 
(Step-by-Step protocols for DNA-sequencing with Sequenase-Version 2.0, 5th ed., 
USB, 1990) 
DNA sequencing was performed by the sequencing facility of the ZMNH. For 
preparation, 1 µg of DNA was diluted in 7 µl ddH20 and 1 µl of the appropriate 
sequencing primer (10 pM) was added.  
 
2.1.11 Mutagenesis via PCR  
(Seamless PCR cloning Kit; Stratagene) 
For investigation of different mutated L1 variants in cell culture and for generation 
of the L1C264Y mouse line, the Seamless PCR cloning Kit (Stratagene) was used 
to delete several nucleotides or to exchange a single base pair within the mouse 
L1cDNA. This kit allows cloning of large DNA fragments without introducing 
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additional restriction sites by combination of higher-fidelity PCR (Pfu DNA 
polymerase) with the activity of the type IIS restriction endonuclease Eam 1104 I 
that cleaves at a defined distance downstream of its recognition sequence. For 
detailed information, see the manufactures instruction.  
In brief, the whole vector pGEM2-L1 (mouse L1cDNA cloned into the EcoRI site of 
pGEM2) was amplified using primers designed such that:  
1. they contain 4 variable bases followed by the recognition side for Eam1160I 
and one additional variable base at the 5´end, 
2.  the following bases directly flanks the region for deletion or contain the desired 
mutation with at least 20 bases homologue to the sequence at the 3´-end. 
The reaction mixture was prepared as followed with 4 different primer sets: 
template (pGEM2-L1)   20 ng 
Mutation-Primer 1 (10 pM)  100 ng 
Mutation-Primer 2 (10 pM)  100 ng 
nucleotides (dNTPs, 40 mM) 1 µl 
10x pfu-polymerase buffer  5 µl  
cloned pfu-DNA-polymerase 1 µl (2.5 U) 
ddH2O       ad 50 µl 
The following step gradient  was applied for mutagenesis: 
cycle 1: 1) Denaturing 95°C  3 min 
  2) Annealing   63°C  1 min  
  3) Synthesis  72°C  13.5 min 
cycle 2-10 and 11-15:  1) Denaturing 95°C  45 sec 
2) Annealing   63°C  35 sec  
3) Synthesis  72°C  13.5 min 
After the 10th PCR-cycle,  to the reaction mixture were added: 
5-methyl dCTP, dA/T/GTPmix (40mM) 1 µl 
10x pfu-polymerase buffer     5 µl 
ddH20          44 µl 
The introduction of 5-methyl dCTP during the last 5 PCR-cycles protects internal 
Eam 1104I recognition sites of the amplified DNA from cleavage with Eam 1104I, 
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whereas the Eam 1104I restriction sites contained in the primers stay Eam 1104I 
sensitive. 
The PCR-product was purified and digested with Eam 1104I in the following 
digestion mixture for 1 h at 37°C: 
PCR-product   0.7 µg 
10x universal buffer 5 µl 
Eam 1104I    4 µl 
ddH20     ad 50 µl 
The Eam 1104I digested DNA-fragment was ligated in the following mixture for 30 
min at 37°C: 
digestion mixture  6 µl 
10x ligase buffer   2 µl 
T4-DNA-ligase (1:16) 1 µl 
Eam 1104I    1 µl 
10 mM ATP   2 µl 
ddH20     8 µl 
Afterwards, the ligation reaction was transformed into XL1-Blue MRF´ 
supercompetent cells (strain that accepts methylated DNA) as described. Single 
colonies were picked from the plate and inoculated into 3 ml cultures. Plasmid 
DNA was prepared and mutation was verified by restriction analysis. The L1cDNA 
was sequenced to exclude introductions of undesired mutations during PCR. 
For expression in cell culture the mutated L1cDNAs were cloned into the 
eucaryotic expression vector pcDNA3 via EcoRI.  
 
2.1.12 Generation of the L1C264Y transgenic mouse line 
2.1.12.1 Construction and preparation of the transgene 
The L1lacZ vector, containing the L1 promoter, a lacZ gene and the NRSE 
sequence (kind gift of P. Kallunki; Kallunki et al., 1997 and 1998; Meech et al., 
1997) was modified to generate a mouse line, expressing the pathogenic 
missense mutation L1C264Y under the control of the L1 promoter. An EcoRI-PvuI-
fragment of the pcDNA3-L1C264Y containing the mouse L1cDNA with the C264Y 
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mutation was initially cloned into the EcoRI-opened vector pBlueCAM-SK(+). The 
lacZ gene was removed from vector L1lacZ by digestion with NotI and XhoI and 
replaced with L1C264Y.  
The 22 kb-transgenic construct was excised from the plasmid by digestion with 
PvuI and SnaBI and separated by gel-electrophoresis. The DNA was extracted 
from the gel by electroelution. Therefore the excised gel was placed into a dialysis 
tube with 2 ml TAE which then was laid in a horizontal electrophoresis chamber 
(BioRad). The tube was covered with 1x TAE buffer and fixed with a glass plate 
and run at constant voltage of 75 V for 120 min. The DNA in the TAE of the tube 
was precipitated and washed with ethanol. 
 
2.1.12.2 Microinjection of the transgenic construct into zygotes  
The linear 22 kb-transgenic fragment was microinjected into DBA-C57BL/6J-hybrid 
zygotes and transplanted into pseudopregnant nurse females using standard 
techniques (Hogan et al., 1994). The microinjections were done in the service 
facility of the ZMBH in Heidelberg. Founder mice were identified by PCR and 
Southern Blot analysis.  
 
2.1.12.3 Breeding of mice 
To verify the expression of each founder line at the protein level, the F1 generation 
of five founders was crossed with heterozygous L1 knock-out (L1ko) females 
(Dahme et al., 1997) to obtain double mutants. For all further investigations 
transgenic males of two founder lines were mated with heterozygous L1 knock-in 
(L1ki) females (L1-deficient mice, generated by insertion of thymidine kinase and 
neomycine-resistance genes into the ninth exon of the L1 gene; 129/SvJ-F6; Rolf 
et al., 2001). Heterozygous L1ki and transgenic females were also crossed with 
129/SvJ wt males. Animals from the second to fifth generation of such crosses 
were used for analysis. 
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2.1.13 Methods for genotyping of mice 
2.1.13.1 Preparation of genomic DNA for genotyping by PCR and Southern 
Blot 
About 3 mm of tail segments were incubated overnight in 250-300 µl Boston buffer 
(supplemented with 150 µg/ml proteinase K) at 56°C. After centrifugation (5 min, 
14,000 rpm) a 1 µl probe of the supernatant was used as template for PCR. 
For Southern Blot analysis the genomic DNA was purified by chloroform 
extraction. 1/6 vol 8 M potassium acetate and 1 vol chloroform was added to the 
lysated tail cut sample and incubated 30 min on ice. After centrifugation (13,000 x 
g, 5 min) the DNA in the upper phase was precipitated by adding 1 ml ethanol 
(absolute) and pelleted by centrifugation (13,000 x g, 10 min). The DNA was 
washed with ethanol (absolute, -20 °C) and 70 % ethanol (-20 °C) and resolved in 
100 µl Tris-HCl, pH 7.0. The purified genomic DNA was digested with BamHI. 
 
2.1.13.2 Genotyping by PCR 
For the genotyping of mice from crosses of heterozygous L1 knock out (L1ko; 
Dahme et al., 1997) with L1C264Y transgenic males two different multiplex PCRs 
(PCR-L1ko and PCR-L1tg) were used to identify the L1ko allel and the L1C264Y 
transgene, respectively, in addition to the endogenous L1wt allel as an internal 
control. The following reaction mixtures were used (for step gradient see PCR-
L1tg-ki below): 
PCR-L1ko: 
template 1 µl 
Primer L1-A´ 1.5 µl 
Primer L1-D 1.5 µl 
Primer L1-C 3 µl 
dNTPs (20 mM) 1 µl 
10x PCR buffer 3 µl 
MgCl2 (50 mM) 1.5 µl 
Taq-polymerase 1 µl 
ddH20 ad 30 µl 
 
PCR-L1tg : 
template 1 µl 
Primer L1-292 1 µl 
Primer L1-709 1 µl 
Primer L1-C 4 µl 
Primer L1-D 4 µl 
dNTPs (20mM) 1 µl 
10x PCR buffer 5 µl 
MgCl2 (50 nM) 2 µl 
Taq-polymerase 1 µl 
ddH20 ad 50 µl 
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For genotyping of animal obtained from crosses of parents with a L1 knock-in allel 
(Rolf et al., 2001) and the L1C264Y transgene, a multiplex PCR was established 
(PCR-L1ki-tg) to identify the L1 knock-in allel the L1C264Y-transgene as well as 
the endogenous L1 gene(s) as an internal control. The following mixture and step 
gradient was used: 
  
PCR-L1ki-tg : 
template 1 µl 
Primer L1-ki 1 µl 
Primer L1-arm 1 µl 
Primer L1 5´up 4 µl 
dNTPs (20mM) 1 µl 
10x PCR buffer 3 µl 
MgCl2 (50 nM) 1.5 µl 
Taq-polymerase 1 µl 
ddH20 ad 50 µl 
Step gradient (for all PCR-genotypings): 
1) Initial denaturing  95°C 2 min 
cycles 1-30: 
2) Denaturing  95°C  45 sec 
3) Annealing 68°C  1.5 min 
4) Synthesis 72°C  1.5 min 
5) Termination 72°C  10 min 
6) Cooling        4°C 
 
 
2.1.14 Southern Blot analysis 
For identification of founder animals, in which the L1C264Y transgene has 
integrated into the genome, Southern Blot analysis were performed in addition to a 
genotyping by PCR. 
 
2.1.14.1 PCR-amplification and labeling of probe  
A 550 bp-probe which binds exclusively to the L1 transgenic construct was 
amplified by PCR for Southern Blot  analysis. The  following mixture was prepared: 
Primer SBtgL1-A 4 µl 
Primer SBtgL1-B 4 µl 
dNTP (25 mM) 1.5 µl 
10x PCR-buffer 5 µl 
MgCl2 (50 mM) 3 µl 
Taq-polymerase 1 µl 
ddH20 ad 50 µl 
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Amplification was performed in a MWG-PCR cycler with the following step 
gradient:  1) Initial denaturing 95°C  4 min 
cycle 1-30: 2) Denaturing   95°C  1 min 
3) Annealing   55°C  1 min 
4) Synthesis   72°C  1 min 
5) Termination  72°C  5 min 
6) Cooling    4°C 
The probe was isolated and purified by gel-electrophoresis and gel-extraction. The 
radioactive labeling was performed in accordance to Sambrook et al. (1989). 
 
2.1.14.2 Gel-electrophoresis and Vacuum-Transfer  
The BamHi-digested genomic DNA was subjected to gel-electrophoresis (1 % 
agarose, 24 cm in length).  The gel was denatured in 2 % HCl for 25 min, washed 
with dH20, and neutralized in 0.4 M NaOH. The DNA was transferred from the gel 
on a nitrocellulose membrane (Hybond N Plus) using a Vacuum-Blot-apparatus 
(BioRad). The blotting sandwich was assembled as described in the manufactures 
protocol. DNA was transferred by applying a vacuum of 300-350 mbar for 90 min. 
 
2.1.14.3 Radioactive detection of DNA on nitrocellulose membrane 
The nitrocellulose membrane was incubated in prehybridization buffer (5x 
Denhardts, 5x SSPE, 0.5 % SDS) over night at 65 °C in a rotator, followed by an 
incubation in hybridization mix (5x Denhardts, 5x SSPE, 0.5 % SDS) over night at 
65 °C. The membrane was washed two times for 30 min in 2x SSC containing 0.1 
% SDS, one time with 1x SSC contacting 0.1 % SDS and finally two times by 0.1x 
SSC containing 0.1 % SDS. The membrane was exposed to X-ray film (Biomax-
MR, Kodak) for 3 days. 
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2.2 Protein-biochemical methods 
2.2.1 SDS-poly-acrylamide gel electrophoresis 
(Laemmli, 1970) 
Separation of proteins was performed by means of the discontinuous SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) using the Mini-Protean III system 
(Bio-Rad). The size of the running and stacking gels were as follows: 
Running gel: height 4.5 cm, thickness 1 mm 
 8 % acrylamide solution 
Stacking gel: height 0.8 cm, thickness 1 mm 
 5 % (v/v) acrylamide solution 
 15-well combs 
After complete polymerization of the gel, the chamber was assembled as 
described by the manufactures protocol. Up to 25 µl sample were loaded in the 
pockets and the gel was run at constant voltage at 80 V for 10 min and then for the 
remaining time at 140V. The gel run was stopped when the bromphenolblue line 
has passed the end of the gel. Gels were then either stained or subjected to 
Western blotting. 
 
2.2.2 Western Blot-analysis 
2.2.2.1 Electrophoretic transfer 
(Towbin et al., 1979) 
Proteins were transferred from the SDS-gel on a nitrocellulose membrane (Protran 
Nitrocellulose BA 85, 0.45 µm, Schleicher & Schüll) using a MINI TRANSBLOT-
apparatus (BioRad). After equilibration of the SDS-PAGE in blot buffer for 5 min, 
the blotting sandwich was assembled as described in the manufactures protocol. 
Proteins were transferred electrophoretically at 4°C in blot buffer at constant 
voltage (70 V for 150 min or 35 V overnight). The prestained marker BenchMark 
(Gibco BRL) was used as a molecular weight marker and to monitor 
electrophoretic transfer.  
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2.2.2.2 Immunological detection of proteins on Nitrocellulose membranes 
(Ausrubel, 1996) 
After electrophoretic transfer, the membranes were placed protein-binding side up 
in glass vessels. Membranes were incubated in 8 ml blocking buffer for 1.5 h at 
room temperature. Afterwards, the primary antibody was added in the appropriate 
dilution overnight at 4°C. The primary antibody was removed by washing the 
membrane 5 x 5 min with PBS-0.05 % Tween. The appropriate secondary 
antibody was applied for 2 h at RT. The membrane was washed again 5 x 5 min 
with PBS-0.05 % Tween and immunoreactive bands were visualized using the 
enhanced chemiluminescence detection system (Pierce). The membrane was 
soaked for 1 min in detection solution (1:1 mixture of solutions I and II). The 
solution was removed and the blot was placed between two saran warp foils. The 
membrane was exposed to X-ray film (Biomax-MR, Kodak) for diverse time 
periods. 
 
2.2.2.3 Densidometric evaluation of band intensity 
Band densities were quantified using the image processing software Scion Image 
(Scion Corporation, Frederick, MD, USA). The developed film was scanned and 
the digitized picture was exported to Scion Image. Band densities were evaluated 
using the “Gelplot2”-macro according to the manual. 
 
2.2.3 Lysis of CHO-cells 
After maintenance of CHO cells in 35 mm-culture dishes, the medium was 
removed and cells were lysed in 400 µl RIPA buffer per 35 mm well with constant 
agitation (1 h, 4°C). Cells were scraped of the wells and transferred into a 1.5 ml 
Eppendorf tube. Debris was removed by centrifugation (15,000 x g, 4°C, 10 min) 
and the supernatant was stored at –20°C. 
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2.2.4 Preparation of crude brain homogenates 
The brains of embryonic (17.5-day-old, n = 2 per genotype) or adult (3-month-old, 
n = 2 per genotype) mice were homogenized in 300 µl or 1 ml lysis buffer LB2 (20 
mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% NP-40, 1x 
COMPLETE protease inhibitor cocktail), respectively, with a potter (Kinematica, 
Luzern) and incubated for 30 min at 4°. The homogenates were cleared by 
centrifugation three times at 12,000 x g for 20 min at 4°C. 
 
2.2.5 Fractioned preparation of brain homogenates 
The brains of 12 129SvEv mice of the 5th postnatal day were homogenized in 5 ml 
lysis buffer LB1 (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM 
EGTA, 1x COMPLETE protease inhibitor cocktail). The cell nuclei were pelleted at 
1000 x g for 10 min at 4°C and resuspended in 2.9 ml LB1. To further purify the 
nuclei fraction, the centrifugation step was repeated three times and it was finally 
solubilized in 3 ml LB2 (LB1 containing 1% NP-40). The collected and united 
supernatants were ultra-centrifuged at 100,000 x g for 1 h at 4°C. The pellet was 
washed three times with LB1 and washing steps were performed in a head-over-
roller for 20 min at 4°C. The collected supernatants represented the cytosolic 
fraction. The pellet was solubilized over night in 3.6 ml LB2. After centrifugation at 
100,000 x g for 1 h at 4°C the supernatant containing the membrane fraction was 
separated from the pellet. The pellet was washed three times for 20 min in LB2 
and finally resuspended in 2 ml LB3 (12.5 mM Tris-HCl, pH 7.5, 0.4 % SDS, 1x 
COMPLETE protease inhibitor cocktail) and solubilized at 95°C for 1 h. After a final 
centrifugation at 20,000 x g for 15 min at RT the supernatant contained 
cytoskeletal proteins. 
 
2.2.6 Endoglycosidase H digestion of CHO cell lysates and brain 
homogenates 
Cell lysates or brain homogenates were diluted with 2x citrate buffer (75 mM 
sodium-citrate, pH 5.5) and after addition of 0.1 U endoglycosidase H (endo H, 
Roche Diagnostics) lysates were incubated at 37°C overnight. Controls were 
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treated identically without addition of endo H. Lysates were subjected to SDS-
PAGE and probed with mc-anti-L1-555 or pc-anti-L1-b. 
 
2.2.7 Determination of protein concentration (BCA) 
(Ausrubel, 1996) 
The protein concentration of cell lysates or brain homogenates was determined 
using the BCA kit (Pierce). For preparation of the BCA solution, solution A and B 
were mixed in a ratio of 1:50. 20 µl of the cell lysate were mixed with 200 µl BCA 
solution in microtiter plates and incubated for 30 min at 37°C. A BSA standard 
curve was co-incubated ranging from 100 µg/ml to 2 mg/ml. The extinction of the 
samples was determined at 568 nm in a microtiter plate reader. 
 
2.3 Cell culture 
2.3.1 CHO and TE671 cell culture 
CHO and TE671 cells were either cultured in GMEM or DMEM, respectively, at 
37°C, 5 % CO2 and 90 % relative humidity in 80 cm2 flasks (Nunc) with 15 ml 
medium or in six-well plates (d = 35 mm; area = 9,69 cm2) with 2 ml medium. Cells 
were passaged when they were confluent (usually after 3-4 days). Medium was 
removed and cells were detached by incubation with 4 ml versene for 5 min at 
37°C. Cells were centrifuged (200 x g, 5 min, RT) and the pellet was resuspended 
in 10 ml fresh medium. Cells were splited 1:10 for maintenance or seeded in six-
well plates for transfection (300 µl per well). 
For immunocytochemistry, cells were seeded on poly-L-lysine coated coverslips (d 
= 14 mm). Coverslips were first cleaned by extensive washing with acetone and 
then air-dried. Coverslips were coated with poly-L-lysine by constant agitation at 
4°C overnight in a poly-L-lysine solution (50 µg/ml in PBS). Finally, they were 
washed twice with ddH2O and dried under a sterile hood. Two coverslips were 
placed per 35 mm dish and cells were seeded with a density of 30 % confluency 
24 h before use.  
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2.3.2 Transient transfection of CHO and TE671 cells 
(Lipofectamine Plus manual, Life technologies) 
For transfection of CHO or TE671 cells, the Lipofectamine Plus kit (Life 
Technologies) was used and performed as described in the manufactures 
protocol. One day before transfection, 2 x 105 cells were seeded per 35 mm dish. 
When cell density had reached 80-90 % (usually after 18-24 h) the cells were 
washed with GMEM/DMEM Ø FCS and antibiotics and transfected with 2 µg total 
DNA per 35 mm well. 6 µl Plus reagent and 4 µl Lipofectamine were used per well. 
Transfection was terminated after 3 h by addition of an equal volume of 
GMEM/DMEM with 20 % FCS, 2 % P/S. 18 h after transfection, cells were 
detached with 500 µl versene per well and splitted for biochemical analysis and/or 
splitted on coverslips for immunocytochemistry. 
 
2.3.3 Stable transfection of CHO cells 
The transfection was carried out as described (see above). To obtain clonal 
transfected cells, constructs of the pcDNA3 vector containing different mutated L1 
or L1wt cDNA were transfected. The pcDNA3 vector encodes a geneticin (G418; 
Life Technologies) resistance. 24 h after transfection the cells were passaged into 
two 90 mm wells and maintained in selection medium (DMEM, 10 % FCS) 
containing 800 µg/µl G418 and the medium was exchanged every second day to 
remove dead cells. After two weeks of selection single colonies have grown and 
were isolated. Cells were washed two times with HBSS and sterile cloning rings 
covered with silicon fat at the bottom were placed on single clones. The cells 
within the ring were detached with 10 µl versene for 5 min, resuspended after 
adding 60 µl GMEM-10 % FCS, and plated in 12 mm wells. The cell clones were 
cultivated until they had grown to confluency in a 80 cm2 flasks (4th passage, after 
3 weeks). From now on, the cells were maintained in DMEM-10 % FCS containing 
300 µg/ml G418 and aliquots of the clones were frozen from the 5th to the 9th 
passage.  
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2.3.4 Surface biotinylation of transfected CHO cells 
Surface biotinylation were essentially carried out as described by Schmidt et al. 
(1997). In brief, 48 or 72 h after transfection, cells were washed twice with ice-cold 
PBS-CM. Surface proteins were biotinylated by incubating cells with 0.5 mg/ml 
Sulfo-NHS-SS-biotin (Pierce, Rockford, IL, USA) in PBS-CM for 10 min at 4°C. 
Biotinylation was terminated by incubation with 20 mM glycine in PBS-CM at 4°C 
for 10 min followed by extensive washing with PBS-CM. Biotinylated cells were 
then lysed directly in RIPA-buffer. The biotinylated proteins were precipitated with 
streptavidin-coupled agarose beads (Pierce) at 4°C overnight. Agarose beads 
were pelleted by centrifugation and washed twice with RIPA-buffer. Precipitated 
proteins were solubilized by addition of 5x SDS-sample buffer to the agarose 
beads. Proteins were separated by SDS-PAGE and proteins were quantified by 
immunoblot analysis using mc-anti-L1-555. 
 
2.4 Immunocytochemistry 
2.4.1 Immunocytochemistry of living cells 
Coverslips with the attached cells were washed with PBS-5 % FCS and placed on 
parafilm (American National Can, Menasha, WI, USA) in a humid chamber. 80 µl 
of mc-αL1-555 were added on the coverslips and incubated at 4°C for 30 min. 
Coverslips were put into 12-well dishes and washed three times with PBS-5 % 
FCS. Then coverslips were put on parafilm again, covered with 80 µl PBS-5 % 
FCS containing the fluorescent dye-coupled secondary antibody in a 1:200 
dilution, and incubated at 4°C for 20 min in the dark. Finally, coverslips were 
washed twice with PBS-5 % FCS, fixed with 4 % PA in PBS, washed with PBS 
and mounted on slides with Aqua Poly-Mount medium (Polysciences Inc). 
 
2.4.2 Immunocytochemistry of fixed cells 
The medium was removed from the coverslips and cells were fixed with 1 ml of 4 
% PA in PBS for 15 min at 4°C and washed twice with PBS. Coverslips were 
placed on parafilm in a humid chamber and incubated with 80 µl 1 % BSA in PBS 
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for 1 h at RT. The blocking buffer was removed by aspiration and the coverslips 
were covered and incubated with 80 µl of mc-αL1 555 overnight at 4°C in a humid 
chamber. Coverslips were washed three times with 0.1 % BSA in PBS and 
incubated with 100 µl antibody solution containing the fluorescent dye-labeled 
secondary antibody (Cy3, Cy5, FITC) for 1 h at room temperature in the dark. 
Finally, cells were washed three times with PBS and mounted on objectives with 
Aqua Poly-Mount medium (Polysciences Inc).  
 
2.4.3 FACS (fluorescence activated cell sorting) 
Confluent stably transfected cells in a 80 cm2 flask were washed with HBSS, 
detached with versene, and resuspended in 1 ml buffer (5 % FCS in PBS).  After 
centrifugation (300 rpm) the cells were incubated with undiluted mc-αL1 555 for 30 
min at 4°C. Cells were washed twice in 5 ml buffer and incubated with goat anti-rat 
IgG conjugated with Cy2 (1:300 in buffer) for 20 min at 4°C. After washing three 
times with 1 ml buffer, cells were fixed in 2 % PA for 5 min and washed again in 
PBS. Finally the cells were resuspended in PBS. Flow cytometric analysis was 
performed using a FACSCalibur System according to the manufactures protocol 
(Becton Dickinson, Heidelberg, Germany). 
 
2.5 Morphological methods 
2.5.1 Immunostaining of Tissue Sections 
4-week- and 10-week-old animals were deeply anaesthetized by an intraperitoneal 
injection of 4 µl narcorene per g body weight and perfused through the left heart 
ventricle with 4 % PA in PBS for 20 min. The brains were prepared and post-fixed 
over night in the same fixative. Vibratome sections, 25-30 µm in thickness, were 
blocked in PBS containing 1% BSA and 0.5% Triton X-100 for 1.5 h, and 
incubated overnight at 4°C with polyclonal L1 antibodies. After washing 5 times 
with PBS containing 0.1 % BSA, primary antibodies were visualized with Cy3-
conjugated secondary antibodies. The sections were washed 3 times with PBS 
and analyzed using an Axiophot (Zeiss). 
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2.5.2 Light and electron microscopy 
70- to 75-day-old mice were deeply anaesthetized with 4 µl narcorene per g body 
weight and perfused with 4 % PA and 3 % glutaraldehyde in PBS for 40 min. 
Brains and sciatic nerves were prepared and post-fixed for 2 to 4 weeks. Frontal 
vibratome sections of the brainstem, 400 µm in thickness, and whole sciatic 
nerves were immersed in 2% OsO4 for 2 h, dehydrated in an ascending series of 
methanol and embedded in Epon resin.  
For light microscopic analysis of the corticospinal tract (CST), semithin sections, 4 
µm in thickness, were prepared from caudal levels of the medulla and stained 
with 0.1 % toluidine blue and 0.1 % methylene blue in 4 % Na2CO3 in H20. The 
area of the CST was measured at caudal levels of the medulla immediately rostral 
to the pyramidal decussation using a computer-assisted image analysis system 
(Neurolucida, Microbrightfield, Colchester, UK).  
For electron microscopic analysis of the peripheral nervous system, ultrathin 
sections were prepared from sciatic nerves and counterstained with lead citrate. 
Micrographs from randomly selected unmyelinated fibers were taken at a 
magnification of 8,000 x with a Zeiss EM10 electron microscope. For each animal 
25–35 unmyelinated fibers were quantified.  
 
2.5.3 Tracing of the corticospinal tract 
Three injections of the lipophilic fluorescent dye 1,1´-dioctadecyl-3,3,3´,3´-
tetramethylindocarbocyanine perchlorate (DiI, dissolved in dimethylformamide 
(Sigma, Deisenhofen, Germany) were made unilaterally into the motor cortex of 
deeply anaesthetized mice at postnatal day one or two with a multi-channel 
picospritzer (General Valve, Fairfield, NJ, USA). After 1–2 days (at P3–4), brains 
were removed and immersion-fixed in PBS, pH 7.4 containing 4 % PA for 3–5 
days. Frontal vibratome sections, 50 µm in thickness, were prepared starting at 
rostral levels of the medulla and ending at cervical levels of the spinal cord. Only 
animals with unilateral tracing of corticospinal axons were analyzed.  
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III Results 
1 Part I: Cell culture experiments 
1.1 Mutagenesis of mouse L1cDNA  
Five different mutant variants of murine L1cDNA were constructed (Fig. 6): L1 
lacking exon 2 (∆E2; deletion of bp 77–91) or exon 27 (∆E27; deletion of bp 3540–
3551), or both (sL1); L1 lacking the putative homophilic binding side of 14 amino 
acids from residue His177 to Gly190 (L1∆hbs; deletion of bp 529–570; Zhao et al., 
1998), and L1 with the pathogenic missense mutation C264Y (L1C264Y; G to A 
substitution of bp 788, Jouet et al., 1993). In addition, a L1 construct containing the 
extracellular, transmembrane and the first nine amino acids of the intracellular 
domain (aa 1–1152) in fusion with a HA-tag (kind gift of P. Kallunki) was used. 
 
L
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Figure 6: Location and type of mutations in L1 variants investigated in cell culture 
experiments. Deletion of amino acids are indicated by Y-shaped lines; the single amino acid 
exchange (C264Y) is marked by a circle. Affected amino acid residues with pathological relevance 
are shown in green. 
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1.2 Cell surface expression of L1∆hbs and L1C264Y is strongly 
reduced  
The localization of L1wt, sL1, L1∆E2, L1∆E27, L1ex, L1∆hbs, and L1C264Y on 
the surface of CHO cells was investigated by immunostaining of live cells 36, 48 
and 72 h after transfection with the different constructs (Fig. 7: 36 h). A high 
percentage of L1 immunopositive cells (about 70-80 %) was found in cultures 36 h 
after transfection with L1wt, L1∆E27, and L1ex. Cultures transfected with L1∆E2 
and sL1 contained slightly fewer immunoreactive cells (40-60 %). In contrast, the 
percentage of L1-immunopositive CHO cells expressing L1∆hbs and L1C264Y 
was very low (about 10-20 %), particularly for L1C264Y-transfected cultures. The 
variability in labeling intensities of L1wt-, sL1-, L1∆E2-, L1∆E27-, and L1ex-
transfected cells was very broad, ranging from weakly to intensely stained cells. In 
comparison, only strongly labeled cells were found in cultures transfected with 
L1∆hbs and L1C264Y. 
 
 
Figure 7: L1 immunocyto-
chemistry of live CHO cells 36 h 
after transient transfection with 
L1wt and mutated L1 (as 
indicated). The majority of cells in 
cultures transfected with L1wt, 
sL1, L1∆E2, L1∆E27, and L1ex is 
L1 immunoreactive. In contrast, 
only a few L1-positive cells are 
detectable in cultures transfected 
with L1∆hbs or L1C264Y. phase: 
Representative phase contrast 
photomicrograph of a culture 
transfected with L1C264Y. Bar in 
phase (for all images): 100 µm. 
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L1 immunostainings 48 and 72 h post-transfection showed an even stronger 
decrease in the number of L1∆hbs- and L1C264Y-immunopositive cells when 
compared to cultures transfected with L1wt, L1∆E2, L1∆E27, sL1 or L1ex (data not 
shown). In fact, in L1C264Y-transfected cultures, labeled cells were virtually 
absent 72 h after transfection. The number of sL1- and L1∆E2-transfected cells 
with cell surface expression of L1 did not decrease in relation to L1wt. Similar 
results were obtained from TE671 cells transfected with the different L1cDNA 
constructs. 
For analysis of long-term expression, CHO cells were stably transfected with 
L1wt, L1∆E2, L1∆E27, L1ex, L1∆hbs, and L1C264Y. For each construct, six 
clones were stained as live cells with anti-L1 antibodies and analyzed by FACS to 
determine the number of positive cells. The percentage of L1-positive cells in the 
clonal cultures was estimated for all L1 mutations and related to L1wt (set to 100 ± 
9.7 %; Fig. 8). The percentage of cells expressing L1ex (88.6 ± 30.0 %) or L1∆E27 
(92.5 ± 31.6 %) on their surface was similar to that of L1wt cells. In contrast, only 
9.5 % (± 6.7 %) of cells were labeled in L1∆hbs-transfected cultures. The 
percentage of positive cells in L1C264Y-transfected cultures (3.5 ± 1.3 %) was in 
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n.s. n.s. Figure 8: The percentage of 
CHO cells with cell surface 
expression of L1 after stable 
transfection with different L1 
constructs. CHO cells were 
stably transfected with L1wt, 
L1∆E2, L1∆E27, L1ex, L1∆hbs, 
and L1C264Y and the percentage 
of cells expressing L1 on their 
surface was determined using 
FACS analysis (the percentage of 
L1-immunoreactive cells in 
cultures transfected with L1wt
 was set to 100 %). A similar percentage of cells with surface expression of L1 is present in cultures 
transfected with L1wt, L1∆E27, and L1ex. In comparison, L1-positive cells are hardly detectable in 
cultures transfected with L1∆hbs or L1C264Y. The number of positive cells transfected with L1∆E2 
is significantly reduced. Mock-transfected CHO cells served as a negative control. Bars represent 
mean values ± SD of six independent experiments for each construct. n.s.: not significantly different 
from L1wt; ?: significantly different from L1wt (p<0.01; Mann-Whitney-test). 
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the range of mock-transfected cells (3.0 ± 0.8 %). A substantial but in comparison 
to L1wt significantly reduced percentage amount of L1∆E2-transfected cells 
showed L1 surface staining. These findings confirm the qualitative data obtained 
by immunostaining of transiently transfected cells (see above). 
The percentage of L1-immunoreactive cells in L1∆hbs- or L1C264Y-transfected 
cultures was significantly increased when cells were permeabilized prior to 
immunostaining (data not shown). This observation argues against the possibility 
that the low number of L1∆hbs- or L1C264Y-transfected cells with surface 
expression is due to low expression levels or poor transfection efficiency. 
 
1.3 L1∆hbs and L1C264Y are expressed as a protein variant 
with a reduced molecular weight of 190 kD 
To further analyze the expression levels and post-translational modifications of 
the different L1 mutations, CHO cells were subjected to immunoblot analysis (Fig. 
9; 10 B and D). At all time points after transient transfection (36, 48 and 72 h) total 
lysates of these cells contained similar amount of L1 protein, irrespective of the L1 
construct that was used for transfection. This observation argues against different 
L1 expression rates or transfection efficiencies as a reason for the observed 
differences in cell surface localization of the different L1 variants. 36 h post-
transfection (Fig. 9 A), two bands of 220 and 190 kD, characteristic for L1 
expressed in cell culture, were identified for L1wt and all L1 mutations. For the 
L1ex mutation, both bands had a reduced molecular weight (about 200 and 170 
kD) due to the lack of the intracellular domain. The upper 220 kD band 
corresponds to the full length and fully glycosylated form of L1 located at the cell 
surface (Zisch et al., 1997). In cultures transfected with L1wt, sL1, and L1ex, the 
220 kD band had the same intensity as the 190 kD band. In contrast, in L1∆hbs- 
and L1C264Y-transfected cultures, the 220 kD signal was much weaker than that 
of the 190 kD band. After longer time periods post-transfection (48 h: Fig. 10 B; 72 
h: Fig. 10 D), the ratio between the intensity of the 220 and 190 kD band shifted 
slightly in favor of the lower one for all constructs. As a result, the 220 kD band 
was very faint in L1∆hbs-transfected cultures and almost absent for L1C264Y-
transfected cultures 72 h after transfection. 
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Similar results were obtained for CHO cells stably transfected with L1wt, L1∆E2, 
L1∆E27, L1ex, L1∆hbs, L1C264Y and L1ex (Fig. 9 B). Both, the 220 and the 190 
kD band were present in lysates of L1wt-, L1∆E2-, L1∆E27-, and L1ex-transfected 
cells. In L1∆hbs- and L1C264Y-transfected cultures, only one single band at 190 
kD was detectable. Interestingly, in lysates of L1ex-transfected cell clones a more 
intense 140 kD band was detectable compared e.g. to L1wt, which indicates an 
increased proteolytic cleavage (Fig. 9B). 
 
 
 
Figure 9: L1 immunoblot analysis of lysates from transiently (A; 36 h after transfection) and 
stably (B) transfected cells. L1-immunoreactive bands at 220 and 190 kD are detectable in 
cultures transfected with L1wt, sL1, and L1ex (A). The reduced molecular weights in cells 
transfected with L1ex are related to the lack of the intracellular domain. In cultures transiently 
transfected with L1∆hbs or L1C264Y (A), the 190 kD form of L1 is strongly expressed whereas the 
220 kD form is hardly detectable. The 220 and 190 kD form of L1 are expressed in cultures stably 
transfected with L1∆E2, L1∆E27, L1ex and L1wt (B), while only the 190kD band is detectable in 
cultures stably transfected with L1∆hbs or L1C264Y (shown are results from 2 out of 8 independent 
experiments for each construct). Mouse brain homogenates (brain) served as an internal control 
and mock-transfected CHO cells as a negative control (only shown in A). 
 
1.4 L1 with a molecular weight of 190 kD is not expressed on 
the cell surface  
Mutations L1∆hbs and L1C264 showed a decrease in cell surface location and 
in the amount of the 220 kD form with increasing time intervals after transfection. 
Therefore, it is conceivable that the 190 kD band represents a protein not 
expressed at the cell surface. To investigate this hypothesis, protein on the cell 
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surface of transfected CHO cells was biotinylated 48 and 72 h after transfection. 
The biotinylated protein was extracted and analyzed by L1 immunoblotting (Fig. 10 
A and C; B and D show whole cell lysates before extraction of biotinylated protein).  
 
 
Figure 10: Cell surface biotinylation. Extracted biotinylated cell surface proteins (A and C) and 
whole cell lysates (B and D) from transiently transfected CHO cells (A and B: 48 h after 
transfection; C and D: 72 h after transfection) were subjected to L1 immunoblot analysis. Analysis 
of biotinylated proteins from CHO cells transfected with L1wt, sL1 and L1ex reveals a prominent 
band at 220 kD at both time points after transfection (A and C). In cultures transfected with L1∆hbs 
and L1C264Y, in comparison, the 220 kD form of L1 is only weakly expressed 48 h (A) and hardly 
detectable 72 h (C) after transfection. Note that the 190 kD form of L1 is absent from biotinylated 
protein extracts of all transfectants (compare A and B, C and D).  
 
The intensity of the 220 kD band was measured and related to L1wt (100 %; 
Fig. 11). Cells transfected with sL1 (48 h: 89.2 %; 72 h: 92.6 %) and L1ex (48 h: 
84,6 %; 72 h: 105.1 %) expressed similar amounts of the 220 kD form of L1 at the 
cell surface. In comparison, levels of cell surface-associated protein were 
significantly reduced 48 h (45.0 % and 20.4 %) and 72 h (20.4 % and 8.5 %) post-
transfection in L1∆hbs- and L1C264Y-transfected cultures, respectively. Thus, for 
these two mutations, a decrease in L1 expression of about 50 % was observed 
between the two investigated time points. This finding fits well with the decline of 
L1-immunopositive live cells with time after transfection. Remarkably, the amount 
of surface labeled protein of the sL1-transfected cells was not reduced in relation 
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to L1wt. This is in contrast to the immunocytochemical data of transient sL1 and 
L1∆E2- or stably L1∆E2-transfected cells which showed a reduced number of cells 
with surface L1. 
 
 
 
Figure 11: The amount of mutated L1 proteins 
and L1wt at the cell surface of transfected 
CHO cells. The intensities of immunoreactive 
bands of biotinylated proteins (Fig. 10 A and C) 
were determined and related to L1wt (set to 100 
% in each blot) for two time points after 
transfection (A and B). In relation to L1wt, the 
amount of surface L1 was clearly reduced in 
L1∆hbs- and L1C264Y-transfected cells 48 h and 
72 h after transfection and, moreover, decreased 
for both mutations by approximately 50 % 
between both time points (compare A and B). 
Bars in A and B represent the mean values ± SD 
of two independent experiments. 
 
 
Biotinylation of live cells and subsequent immunoblot analysis identified the 220 
kD form of L1 as the major protein form of L1 at the cell surface of transfected 
CHO cells (Fig. 10 A and C). In addition, a faint 160 kD band was found, most 
probably corresponding to the 140 kD proteolytic cleavage fragment of L1 
observed in mouse brain. The broad band at 220 kD might contain an additional 
band, known as the 180 kD proteolytic fragment of L1 from mouse brain (Sadoul et 
al., 1988 and 1989), which is expressed to have a molecular weight of about 200 
kD in this cell line. In contrast, the 190 kD protein form, present in lysates of CHO 
cells transfected with L1wt and the different L1 variants, was not labeled at the cell 
surface, indicating that it is not transported to the plasma membrane, but is instead 
located inside the cell. 
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1.5 L1∆hbs and L1C264Y are not located at the cell surface, but 
within the endoplasmic reticulum 
The most likely explanation for the reduced molecular weight of the L1∆hbs- 
and L1C264Y-variants of L1 is a change in the glycosylation pattern, probably 
resulting from impaired protein transport within the cell. To investigate this 
hypothesis, CHO cells were lysated 72 h after transfection and the protein was 
digested with endoglycosidase H (endo H; Fig. 12). The enzyme removes N-linked 
glycans with terminal mannose residues, characteristic for glycoproteins located in 
the endoplasmic reticulum and early cis-Golgi apparatus during oligosaccharide 
processing (for review see: Helenius and Aebi, 2001; Parodi, 2000a, b). After endo 
H treatment, the 190 kD protein form of L1∆hbs and L1C264Y shifted to a 150 kD 
band, the estimated molecular weight of deglycosylated L1 protein. The same shift 
in molecular weight was observed for the 190 kD band in cultures transfected with 
L1wt, sL1 and L1ex. Therefore, the 190 kD form of L1 has undergone a complete 
cleavage of its glycans by endo H, indicating that it is located within the 
endoplasmic reticulum and, in the case of L1∆hbs and L1C264Y, is not further 
transported through the Golgi network to the cell surface. 
 
 
Figure 12: Deglycosylation of L1wt and mutated L1 by endo H. L1 immunoblot analysis of 
transiently transfected CHO cells (72 h after transfection) either without (-H) or after (+H) digestion 
with endo H. Treatment with endo H does not alter the molecular weight of the 220 kD form of L1, 
while it reduces the molecular weight of the 190 kD form to 150 kD.  
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2 Part II: The L1C264Y transgenic mouse 
2.1 Generation of L1C264Y transgenic mice  
Transgenic mice with an expression of L1C264Y under the control of the L1 
promoter (Kallunki et al., 1998) were generated to establish an animal model for 
this pathogenic missense mutation (Fig. 13).  
 
 
Figure 13: Construct for the generation of L1C264Y mice. This construct comprises the 
regulatory elements of the gene, i.e. the L1 promoter and the NRSE sequence (neural restrictive 
silencer element; kind gift of Pekka Kallunki; Kallunki et al., 1998), the cDNA encoding L1C264Y, 
and the SV40 polyadenlylation site. The entire transgenic construct has a length of about 22 kb. 
 
After microinjection of the transgene into 150 zygotes (second generation of 
crosses between C57B6 and DBA mouse strains) and their implantation into the 
nurse female, 72 mice were born. Out of this animals, five founders carrying the 
transgene were identified by PCR and Southern blot analysis (Fig. 14), four 
females and one male founder. For the male founder, further breeding identified 
the Y-chromosome as the integration site of the transgene.  
 
 
Figure 14: Southern Blot analysis for identification of transgenic founders. The Southern Blot 
reveals a positive signals for animals ´7` and ´14`, which identify them as transgenic founders. 
These founders gave rise to the founder lines L1C264Y-III and -IV. C: control marker. 
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To confirm the expression of the transgenic L1C264Y protein, transgenic mice 
were crossed into a L1-deficient background by breeding males of the first 
generation (into the C57BL/6J mouse strain; L1+/y_C264Y) with C57BL/6J 
heterozygous L1 knock-out females (L1+/-; Dahme et al., 1997). Wild-type (wt), 
L1-deficient (L1-/y), L1+/-, and L1C264Y transgenic male embryos 
(L1−/y_L1C264Y; further termed L1C264Y) at embryonic day 17.5 were used for 
L1 immunoblot analysis (Fig. 15). Substantial amounts of L1C264Y protein were 
expressed in founder line IV (Fig. 15 A) and at lower levels in line III, whereas in 
lines I, II (Fig. 15), and V no L1C264Y protein was detectable.  
 
 
 
 
Figure 15: Amount of L1 protein in brain homogenates from 
mouse embryos (at E17.5) of different genotypes (A). In comparison 
to wild-type (wt) mice, the homogenate of the L1C264Y transgenic 
mouse of the founder line IV (L1C264Y -IV) contains reduced but 
substantial amounts of transgenic protein whereas that of founder line II 
(L1C264Y –II) shows no expression of transgenic L1C264Y protein 
(compare to L1-/y; the band detected in L1-/y corresponds to residual 
L1-immunoreactivity, described for this L1 knock-out line (Dahme et al., 
1997)). Note that the L1C264Y protein has a molecular weight of 190 kD, instead of 200 and 140 
kD as detectable in wt. The amount of L1 in L1+/- is slightly reduced compared to wt brains. (B) In 
brain homogenates of L1+/y_C264Y mice of line IV (expression L1C264Y in addition to 
endogenous L1) the 190 kD protein (white arrowhead) is visible in addition to the 200 kD (black 
arrowhead) and 140 kD protein of endogenous L1 wt. L1-deficient (L1-/y) mice of the L1 knock-in 
mouse line (Rolf et al., 2001) showed no residual L1-immunoreactivity. All used animals in (B) were 
6 weeks of age. 
 
The amount of L1 in transgenic lines III and IV was estimated by quantification 
of band intensities on immunoblots, and was related to L1 levels in wt mice (Fig. 
16). The founder line IV expressed the highest level of L1C264Y protein (34 % 
compared to L1 in wt mice), whereas expression of transgenic L1 in line III was 
significantly lower (11 % compared to L1 in wt mice). Therefore, the founder line IV 
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was chosen for all further investigations (now termed L1C264Y without indication 
of the line), and were crossed into the L1-deficient background by cross-breading 
with L1 knock-in mice (Rolf et al., 2001), in which the L1-/y males showed no 
residual L1 protein (Fig. 15 B).  
 
 
Figure 16: Amount of L1 in wt 
males,  heterozygous  L1ko 
(L1+/-) females and L1C264Y 
transgenic mice of founder lines 
III and IV as revealed by 
quantification of band 
intensities of L1 immunoblots 
(an example is shown in Fig. 15). 
For every genotype or transgenic 
mouse line, the bands of three 
different protein concentration 
concentrations per blot and two different blots were quantified and related to wt. Bars represent mean 
values ± SD of two independent experiments. 
 
2.2 L1C264Y expressed in vivo is endo H-sensitive  
Immunoblot analysis of brain tissue from 17.5-day-old L1C264Y mouse 
embryos revealed a single L1-immunoreactive band of about 190 kD instead of the 
characteristic 200 kD (full length) and 140 kD (proteolytic cleavage product) bands 
found in brain homogenates of wt mice (Fig. 15 A). In brain homogenates of 
L1+/Y_C264Y animals (expressing L1C264Y in addition to endogenous L1) a 190 
kD in addition to a 200  and 140 kD L1 protein form were found (Fig. 15 B). 
Treatment of brain homogenates from L1C264Y males with endo H resulted in 
a shift of the 190 kD band to a 150 kD band (Fig. 17). Molecular weights of L1-
immunoreactive bands in wt homogenates, in contrast, were not altered by endo H 
treatment (Fig. 17). This observation indicates that the 190 kD variant of L1 
expressed in L1C264Y mice represents a not fully glycosylated protein. The same 
results were obtained with brain homogenates of 3-month-old mice (data not 
shown). 
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Figure 17: Brain 
homogenates from 17.5-day-
old wt and L1C264Y 
transgenic mouse embryos 
were subjected to L1 
immunoblot analysis either 
without (-H) or after (+H) 
digestion with endo H. The 
two  antibodies  mc-αL1-555 
(A) and pc-aL1a (B) were used. In undigested samples of wt mice (-H in A and B), the 
characteristic L1-immunoreactive bands at 200 and 140 kD (a proteolytic cleavage product of L1) 
are detectable..These L1wt protein is insensitive to endo H treatment (+H in A and B). In 
comparison, homogenates from L1C264Y transgenic mice contain a 190 kD instead of a 200 kD 
band and lack the 140 kD proteolytic cleavage product of L1 (-H in A and B), and endo H digestion 
results in a shift of the 190 kD band to 150 kD (+H in B). Note that the mc-αL1-555 (A) does not 
recognize the deglycosylated 150 kD protein in samples of L1C264Ymice 
 
2.3 Expression of L1C264Y protein is restricted to cell bodies 
of neurons 
To study the expression pattern and the localization of L1C264Y protein in brain 
tissue by immunohistochemistry, wt, L1C264Y, L1-/y, and L1+/y_C264Y mice 
were perfused and 25 µm thick vibratome sections of diverse regions of the CNS 
were stained with L1 antibodies (Fig. 18 and 19). In wt mice, intense and 
homogeneously distributed L1-immunoreactivity was observed in the molecular 
layer of the cerebellar cortex (Fig. 18 A), in the fiber-rich layers of the 
hippocampus (alveus, strata lacunosum moleculare, radiatum, and oriens; Fig. 19 
A, C, E, F), in the nerve fiber layer and inner and outer plexiform layers of the 
retina (Fig. 18 F), and in the molecular layer of the olfactory bulb (data not shown). 
In contrast, L1-immunostaining in L1C264Y mice was restricted to the somata of 
neurons normally extending L1-positive processes, including Golgi, granule, 
basket, and stellate cells in the cerebellum (Fig. 18 B and E); pyramidal cells (Fig. 
19 B and D), granule cells, and hilar interneurons (Fig. 19 B, F, H) in the 
hippocampus; ganglion, amacrine, and horizontal cells in the retina (Fig. 18 G), 
and mitral cells in the olfactory bulb (data not shown). L1-immunopositive fibers 
were not detectable in the CNS of L1C264Y transgenic mice. In L1+/y_C264Y 
mice, intense L1-immunoreactivity was found in fiber-rich mice brain regions and 
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Figure 18: L1-immunohistochemistry of the cerebellum (A-E) and the retina (F-H) of two-
month-old wt, L1C264Y, or L1-/y mice. Intense and homogenously distributed L1-
immunoreactivity is visible in the fiber-rich brain regions of wt mice, such as the molecular layer of 
the cerebellum (A), and the nerve fiber layer and plexiform layers of the retina (F). Regions rich in 
cell bodies, such as the internal granular layer of the cerebellum (A) or inner and outer nuclear 
layers of the retina (F) are only weakly L1-immunoreactive in wt mice. In contrast, L1-positive fibers 
are absent from the cerebellar cortex (B) or the retina (G) of L1C264Y mice. Instead, intense 
intracellular labeling of Golgi cells (some labeled with arrows in B; E shows a single Golgi cell) and 
weaker intracellular labeling of basket and stellate cells (some labeled with arrowheads in B) is 
visible in the cerebellar cortex of L1C264Y mice. In the retina of these mutants, cell bodies of 
ganglion, horizontal and amacrine cells (G) are strongly stained by L1 antibodies. In L1+/y_C264Y 
mice, both, fiber tracts and nerve cell bodies are labeled by L1 antibodies (D; some 
immunoreactive Golgi cells are labeled with arrows). Sections from L1-/y mice are L1 
immunonegative (C).(H) is the phase contrast photomicrograph of (G). gcl: ganglion cell layer; igl: 
internal granule layer, inl: inner nuclear layer; ipl: inner plexiform layer; ml: molecular layer; onl: 
outer nuclear layer; opl: outer plexiform layer; Bar in D (for A-D): 25 µm; bar in E: 10 µm; bar in F 
(for F-H): 50 µm. 
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Figure 19: L1 immunohistochemistry of the hippocampus of two-month- (A-F) and four-
week-old (G and H) wt (A, C, E, G) and L1C264Y (B, D, F, H) mice. In wt mice, L1-
immunoreactivity is visible in fiber-rich regions, including the stratum oriens, radiatum, and 
lacunosum moleculare (A) and the mossy fibers (C and E). In contrast, in L1C264Y mice only cell 
bodies including pyramidal cells (B and D) and hilar interneurons (F) are intensely labeled. In the 
two-month-old L1C264Y mice the granule cells are only weakly stained (F), whereas in the four-
week-old mice, the granule cells show intense labeling comparable to that of the pyramidal cells 
(G) with the strongest staining of granule cells in the hilar-near subgranular zone. In four-week-old 
wt animals, fibers in the subgranular zone are strongly labeled (G), whereas in two-month-old wt 
mice (E) labeling in this area is reduced. cx: cortex; dg: dentate gyrus; g: granule cell layer; hl: 
hilus; lm: stratum lacunosum moleculare; ml: molecular layer; o: stratum oriens; p: pyramidal cell 
layer; r: stratum radiatum. Bar in A (for A and B): 200 µm; bar in D (for C and D), F (for E and F), 
and H (for G and H): 100 µm. 
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within neuronal cell bodies (Fig. 18 D). Sections from L1-/y mice were L1-
immunonegative (Fig. 18 C). 
In summary, L1C264Y transgenic mice showed a normal spatio-temporal 
expression pattern of transgenic L1 in that transgenic L1 was only detectable in 
cells known to normally express L1 in wt mice, but not in cells known to not 
express L1 wt mice, such as Purkinje cells in the cerebellum or photoreceptor cells 
in the retina (Fig.18 B and G). In addition, expression of L1 in L1C264Y mice was 
developmentally regulated. For example, in four-week-old L1C264Y mice, granule 
cells of the dentate gyrus showed a labeling intensity comparable to that of the 
pyramidal cells of the hippocampus (Fig. 19 H). The most intense labeled granule 
cells were found in the hilus-near part region. These cells might correspond to 
young postmitotic cells, since the vast majority of the granule cells are generated 
postnatally during the first three to four weeks (Bayer, 1980). In contrast, in two-
month-old L1C264Y mice, granule cells were only weakly labeled compared to 
pyramidal cells (Fig. 19 H). 
 
2.4 General phenotype of L1C264Y mice 
Our combined in vitro and in vivo data indicate that the pathogenic missense 
mutation L1C264Y is not expressed at the cell surface. It is thus reasonable to 
assume that the L1C264Y transgenic mouse might be equivalent to a functional 
knock-out mutant, and thus might exhibit a phenotype indistinguishable from that 
of L1-deficient mice. However, it is also possible that an accumulation of mutated 
L1 protein within the cell or a cell surface localization below detection levels result 
in a more severe or less severe phenotype, respectively, compared to L1 null 
mutants. We therefore compared in detail the phenotypes of L1C264Y and L1-/y 
mice.  
Both, L1-/y and L1C264Y mice, had a reduced body size compared to their wt 
littermates, lacrimeous and sunken eyes (Fig. 20), and had difficulties to use their 
hindlegs when hanging on a grid. These general phenotypes were more striking in 
young animals until their fourth postnatal week than in older ones. In contrast, 
L1+/y_C264Y mice (males that express both L1C264Y and wild-type L1) showed 
no general abnormalities and were undistinguishable from wt mice.  
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Figure 20: Three-week-old L1C264Y transgenic (top) and L1-/y mice (bottom) and their wt 
litter. Both mutants display a reduced body size and have lacrimeous and sunken eyes. 
 
The average body weight of ten-week-old L1-/y (25.1 ± 2.6 g, n = 7) and 
L1C264Y mice (25.5 ± 1.5 g, n = 7) was reduced when compared to wt (29.3 ± 1.6 
g, n = 12) and L1+/y_L1C264Y littermates (28.6 ± 1.2 g, n = 5; Fig. 21).  
 
 
Figure 21: Average body weight of 
ten-week-old wt, L+/y_L1C264Y, 
L1-/y, and L1C264Y mice. The body 
weight of L1-/y and L1C264Y, but 
not of L1+/y_L1C264Y mice, is 
reduced compared to age-matched 
wt animals. Bars represent the mean 
values ± SD of 5 to 12 animals. 
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Given an expected ratio of 1:1 between born females and males, the apparent 
survival rate until weaning was strongly reduced for males (32.7 %; Fig. 22 A) 
derived from breedings between L1+/-_C264Y females and wt males. The reduced 
frequency of male offsprings was due to a decreased survival rate of L1C264Y 
and L1-/y males compared to wt male littermates. According to Mendelian 
frequencies, each of the four possible genotypes of males expected to derive from 
the given crosses should appear with a probability of 25 %. We used the number 
of wt males (n = 50) to calculate the percentage of males of the different 
genotypes which reached the age of weaning (Fig. 22 B). According to these 
calculations, the frequency of L1+/y_L1C264Y males was only slightly lower (21.2 
%, n = 42) than expected (i.e. 25 %), whereas the number of both L1C264Y and 
L1-/y mutant males was dramatically lower than theoretically expected (L1C264Y: 
8.0 %, n = 16; L1-/y: 9.5 %, n = 19).  
 
 
Figure 22: The survival rate of males is reduced compared to females (A). L1-/y and 
L1C264Y males showed a strongly reduced survival rate compared to wt and L1+/y_C264Y 
males (B).  
  
2.5 L1C264Y and L1-deficient mice display a similar 
morphological phenotype 
Corticospinal axons of L1-deficient mice display pathfinding errors at the 
pyramidal decussation (Cohen et al., 1998). To evaluate whether similar 
abnormalities are detectable in L1C264Y mice, the CST of wt, L1-/y, and L1C264Y 
mice was anterogradely labeled at postnatal day 1-2. The trajectory of the tract at 
the pyramidal decussation was analyzed 2 days after tracing (Fig. 23).  
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Figure 23: Tracing and trajectory of the corticospinal tract (CST) from the pyramidal cells in 
layer 5 (L5) of the cortex through the diencephalon and medulla to the spinal cord (A). At the 
caudal end of the medulla, the CST turns from ventral to dorsal and crosses the midline to the 
contralateral side (pyramidal decussation), and enters the dorsal funiculus of the spinal cord (B).  
 
 
 
Figure 24: Anterograde tracing of corticospinal axons in wt (A-C), L1-/y (D-F), and L1C264Y 
mice (G-I), and analysis of their trajectory at the pyramidal decussation. In wt mice, 
corticospinal axons cross the midline (indicated by arrowheads in A-I) at the pyramidal decussation 
(A and B) and extend to the dorsal column, where they enter the dorsal funiculus (C). In L1-/y mice, 
corticospinal axons display pronounced pathfinding errors at the pyramidal decussation, and either 
project bilaterally to the dorsal column (D), or cross the midline but stay ventrally instead of 
projecting dorsally (E). A bilateral projection of corticospinal axons to the dorsal column (G) or a 
projection to the contralateral pyramid (H) is also detectable in L1C264Y transgenic mice. Both 
mutants additionally show defasciculation of corticospinal axons (F and I). Bars in A and C: 200 
µm; Bars in B, D-I: 100 µm.  
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In wt mice (n = 5, Fig. 24 A-C), corticospinal axons turned dorsally at the caudal 
end of the medulla oblongata, crossed the midline (Fig. 24 A and B) and extended 
into the contralateral dorsal column (Fig. 24 C). In most L1-/y mice (n = 4, Fig. 24 
D-F), in contrast, a significant portion of axons failed to cross the midline but 
instead projected to the ipsilateral dorsal column (Fig. 24 D). In other L1-/y mice, 
corticospinal axons stayed ventrally and entered the contralateral pyramid (n = 2, 
Fig. 24 E) or stayed ventrally without crossing the midline (n = 1). Pathfinding 
errors of corticospinal axons were also observed at the pyramidal decussation of 
L1C264Y mice (Fig. 24 G-I). Similar to L1-/y mice, a significant fraction of 
corticospinal axons projected to the ipsilateral dorsal column (n = 3, Fig. 24 G), or 
axons stayed ventrally either without crossing the midline (n = 2) or extending to 
the contralateral pyramid (n = 2, Fig. 24 H). One L1C264Y mutant displayed no 
obvious pathfinding errors at the pyramidal decussation. In addition, moderate 
defasciculation of corticospinal axons was observed in both mutant mouse lines 
(Fig. 24 F and I). 
The size of the CST is significantly reduced in L1-deficient mice (Dahme et al., 
1997). Therefore, we determined the area of the CST in ten-week-old wt (Fig. 25 
A), L1-/y (Fig. 25 B), L1C264Y (Fig. 24 C), and L1+/y_L1C264Y mice at the caudal 
end of the medulla (Fig. 25 D). The area of the CST of L1-/y mice was significantly  
 
 
Figure 25: The size of the CST of L1-/y (B) and L1C264Y mice (C) is significantly reduced 
compared to wt mice (A). Quantitative analysis (D) reveals a similar area of the corticospinal tract 
(CST) in wt (n = 7) and L1+/y_C264Y (n = 3) mice. In contrast, the area of the CST is significantly 
reduced to a similar extent in L1-/y (n = 5) and L1C264Y (n = 5) mice. Bars in (D) represent mean 
values ± SD. n.s.: not significantly different from wt; ?: significantly different from wt (p<0.01; 
Mann-Whitney-test). CST: corticospinal tract. Bar in A-C: 100µm. 
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reduced to 66.8 % (56,264 ± 7179 µm2 per tract; n = 5) compared to wt mice 
(84,199 ± 7816 µm2 per tract; n = 7). The CST of L1C264Y mice was reduced to a 
similar extent as that of L1-/y mice (67.9 %; 57,133 ± 7716 µm2 per tract; n = 5), 
while the values for L1+/y_L1C264 mice (96.9 %; 81,572 ± 7043 µm2, n = 3) were 
not significantly different from that of wt animals.  
 
 
Figure 26: Ultrastructure of 
unmyelinated fibers in the 
sciatic nerve of wt, L1-/y, 
and L1C264Y mice. Axons in 
wt mice are ensheathed and 
separated from each other by 
Schwann cell processes. In 
L1-/y and L1C264Y mice, in 
contrast, a portion of axons 
(same labeled with asterisks) 
is not covered by a Schwann 
cell process, and numerous 
nonmyelinating Schwann cells 
extend processes (labeled with 
arrowheads) into the 
endoneurial space. Note the 
reduced number of axons 
associated with one 
nonmyelinating Schwann cell 
in L1-/y and L1C264Y mice 
compared to wt animals. ax: 
myelinated axon; mSC: 
myelinating Schwann cell; 
nSC: nonmyelinating Schwann 
cell. Bar in L1C264Y (for all 
graphs): 1µm. 
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Morphological abnormalities of unmyelinated fibers in peripheral nerves of L1-
deficient mice include a reduced number of unmyelinated axons per 
nonmyelinating Schwann cell, Schwann cell processes extending into the 
endoneurial space, and the presence of incompletely ensheathed unmyelinated 
axons (Dahme et al., 1997; Haney et al., 1999). To investigate if L1C264Y mice 
exhibit similar defects, we examined unmyelinated fibers in sciatic nerves of ten- to 
eleven-week-old wt, L1-/y, and L1C264Y mice. In wt animals, nonmyelinating 
Schwann cell processes ensheathed individual axons whereas in both, L1-/y and 
L1C264Y (Fig. 26; n = 6 for each genotype) mutant mice, a portion of axons were 
either incompletely or not ensheathed by Schwann cell processes. Instead, these 
axons were either covered by a basal lamina or were in direct contact with each 
other (Fig. 26, asterisks).  
 
 
Figure 27: Quantitative analysis of 
ultrastructural abnormalities in the sciatic 
nerve of wt, L1-/y, and L1C264Y mice. The 
number of incompletely ensheathed axons per 
nonmyelinating Schwann cell (A), and the 
number of nonmyelinating Schwann cells 
extending one or more processes into the 
endoneurium (B) is significantly increased, and 
the number of axons associated with a 
nonmyelinating Schwann cell (C) is significantly 
decreased in L1-/y and L1C264Y mice when 
compared to wt animals. Note that values for L1-
/y and L1C264Y mice are not significantly 
different from each other for all parameters 
analyzed (A-C). Bars in (A-C) represent mean 
values ± SD from six animals for each genotype. 
SC-processes: Schwann cell processes; n.s.: not 
significantly different; ?: significantly different 
(p<0.01; Mann-Whitney-test). 
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The percentage of axons with an incomplete (less than half of the axonal 
circumference) ensheathment by Schwann cell processes (Fig. 27 A) was 
significantly increased to a similar extent in L1-/y (22.5 ± 3.6 %) and L1C264Y 
(26.7 ± 4.4 %) mice, when compared to wt mice (7.3 ± 2.5 %). Moreover, 
nonmyelinating Schwann cells of both mutant mouse lines extended additional 
processes into the endoneurial space (Fig. 26 B and C, arrowheads; Fig. 27 B). In 
wt mice, 8.2 ± 4.2 % of nonmyelinating Schwann cells extended such additional 
processes into the endoneurium compared to 73.4 ± 7.8 % and 79.9 ± 9.1 % in L1-
/y and L1C264Y mutants, respectively (Fig. 27 B). Finally, the number of 
unmyelinated axons associated with one nonmyelinating Schwann cell was 
significantly and similarly reduced in L1-/y (9.0 ± 1.9 axons per unit) and L1C264Y 
(9.9 ± 2.0 axons per unit) compared to wt mice (20.3 ± 4.4 axons per unit; Fig. 27 
C). 
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IV Discussion 
Mutations in all parts of the human L1 gene cause severe neurological 
diseases, termed L1 spectrum. The disorder is characterized by increased 
mortality, mental retardation and various malformations of the nervous system 
(Fransen et al., 1995). Missense mutations in the human L1 gene affecting the 
extracellular domain often result in a severe phenotype, whereas mutations in the 
highly conserved cytoplasmic domain generally cause a more moderate clinical 
picture. In an attempt to understand the reasons for the frequent occurrence of 
severe missense mutations in the extracellular domain of L1, this study focused on 
the functional consequences of extracellular and cytoplasmic L1 mutations in vitro. 
To this aim, we used mutated L1 constructs, sL1 or L1∆E2 and L1∆E27, L1ex, 
L1∆hbs, and L1C264Y, to study their expression in CHO cells. Moreover, a 
transgenic mouse line was generated expressing the human pathogenic missense 
mutation C264Y in the extracellular domain. The mutant was used to study the 
expression of this L1 variant in vivo and the consequences of this mutation on the 
development of the nervous system. The present study demonstrates impaired 
trafficking of the mutated L1 variants L1∆hbs and L1C264Y to the cell surface in 
vitro. Impaired trafficking of L1C264Y was also observed in vivo, resulting in 
severe morphological deficits of the L1C264Y transgenic mouse that are 
undistinguishable from the deficits observed in L1-deficient mice. 
 
1 The short isoform of L1 
Cultures of CHO cells transiently transfected with sL1 showed a reduction of the 
number of cells with surface L1 immunoreactivity compared to cultures transfected 
with L1wt. The impaired transport of this L1 variant to the cell surface is due to the 
lack of exon 2, since cultures transiently or stably transfected with L1∆E2 showed 
the same reduction in the number of cells with surface L1, whereas the number of 
L1∆E27-transfected cells with surface L1 was comparable to those transfected 
with L1wt. However, a reduction of surface sL1 could not be verified by 
quantification of the amount of cell surface biotinylated L1. A possible explanation 
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for this observation is that cells with surface expression of sL1 expressed higher 
amounts of L1 protein than cells expressing L1wt or L1ex. 
As exon 2 is not included in L1 expressed by neurons and is located between 
the signal peptide and the first Ig domain it would be reasonable to assume that 
the absence of exon 2 alters protein trafficking of L1. This possibility was recently 
excluded by a study in which cerebellar neurons and chick dorsal root ganglion 
cells were transfected with L1lacking exon2, since no alterations in its distribution 
on the cell body and along neurites were found in comparison to full-length protein 
(De Angelis et al., 2001). However, since the amount of surface L1 was not 
determined in this study, we can not exclude that our observations on sL1-/L1∆E2-
transfected CHO cells related to the particular cell type used in our study.  
It has also been demonstrated that binding of L1∆E2 to itself or full-length L1 is 
dramatically or moderately reduced, respectively. In addition heterophilic binding 
of L1∆E2 to TAX-1 and F3 was impaired (De Angelis et al., 2001). The findings of 
reduced homophilic binding abilities of L1∆E2 were confirmed and extended by 
another study showing diminished levels of neurite outgrowth from cerebellar 
neurons on a L1∆E2 substrate (Jacob et al., 2002). The combined data lead to the 
suggestion that exon 2 provides a ´spacer`, allowing N-terminal residues to 
interact with the junction between Ig domains 4 and 5 in the proposed horseshoe 
structure of the first 4 Ig domains (Su et al., 1998; Freigang et al., 2000; De 
Angelis et al., 2001; Jacob et al., 2002). Therefore the data provides an 
explanation for certain pathological mutations affecting exon 2 of L1 that cause L1 
spectrum (Jouet et al., 1995 b; Finck et al., 2000; De Angelis et al., 2001). 
 
2 The L1 mutations L1C264Y and L1∆hbs result in 
impaired protein trafficking 
When CHO cells were transiently transfected with L1C264Y and L1∆hbs, 
significantly reduced amounts of protein were found at the cell surface compared 
to L1wt, sL1, or L1ex. Cell surface levels of L1∆hbs and L1C264Y decreased 
further with increasing time after transfection. Furthermore, stably transfected 
CHO cells did not express detectable levels of the L1∆hbs and L1C264Y variants 
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at their cell surface. However, immunoblot analysis of total cell culture lysates 
revealed similar amounts of L1 protein for all L1 variants analyzed (i.e. L1wt, sL1, 
L1∆E2, L1∆E27, L1ex, L1∆hbs, and L1C264Y), demonstrating a similar 
transfection efficiency for all constructs. While a prominent 220 kD band was 
observed in L1wt-, sL1-, and L1ex-transfected cells, this band was very weak in 
short-term and absent in long-term cultures transfected with the L1∆hbs or 
L1C264Y constructs. Instead, for these two mutations, a 190 kD form of L1 was 
detected as the prominent L1-immunoreactive band. This 190 kD form was not 
labeled in cell surface biotinylation experiments, indicative for an intracellular 
localization of L1∆hbs or L1C264Y. To discuss these and further data about these 
L1 mutations in more detail, the general mechanisms of how mutated proteins can 
be retained intracellularly are illustrated in the next chapter. 
 
3 Retention of misfolded proteins in the ER 
The ER is the subcellular site where glycoproteins such as L1 are synthesized, 
acquire their proper folding, and become de novo N-glycosylated. In addition, the 
ER contains mechanisms to monitor the fidelity of these early biosynthetic events 
of the proteins. This has been called ´ER quality control', a mechanism that 
prevents export of incompletely or improperly folded proteins from the ER to the 
Golgi apparatus (Hammond and Helenius, 1995; Kopito, 1997). Therefore, cellular 
systems have evolved sets of ER resident helper proteins termed ´molecular 
chaperons` which facilitate folding of proteins and counteract misfolding and 
aggregation during the folding process. Examples for such proteins in the ER are 
family members of Hsp70 (heat shock protein 70; e.g. BiP (immunoglobulin heavy 
chain-binding protein); Bukau and Horwich, 1998), Hsp90 (Grp94 (glucose 
regulated protein); Bose et al., 1999), and lectin (carbohydrate-binding proteins) 
chaperones (calnexin, calreticulin) (Beissinger and Buchner, 1998). For example, 
calnexin (CNX), a membrane-associated lectin, is involved in the processing of N-
linked glycoproteins and is part of the ER quality control, by which misfolded 
proteins may be retained in the ER (Parodi, 2000 a, b). 
Biosynthesis of all N-linked oligosaccharides starts in the rough ER with 
cotranslational transfer of a dolichol-P-P-linked precursor oligosaccharide 
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(Glc3Man9GlcNAc2) to Asn residues in nascent polypeptide chains (Fig. 30; step 
1). From the triglucosylated core glycan three glucose and one mannose residues 
are cleaved off by three different enzymes (glucosyltransferase I and II, α-
mannosidase; Fig. 30; step 2 and 3). During this process of glycan trimming, 
glycoproteins get also folded, assisted by chaperones and mediated by 
isomerases. Correctly folded proteins are then able to exit from the ER to the Golgi 
network for further processing of the glycans. The ER resident enzyme 
glucosyltransferase is able to add one glucose residue to the Man7-9 
oligosaccharide which is linked to unfolded or misfolded, thus not correctly folded 
glycoproteins (Fig. 30; step 3a). This enzyme is therefore a sensor for the folding 
state of glycoproteins. Subsequently, CNX selectively binds monoglucosylated 
glycans and prevents folding of the adjacent amino acid segments. The removal of 
the terminal glucose by glucosyltransferase II releases the ligand from CNX. If 
protein folding is still incomplete, a next cycle of CNX binding is initiated to drive 
the folding process towards completion. Thus, CNX prevents premature folding 
and aggregation of newly made proteins, therefore allowing a functional interaction 
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Figure 28: Addition and initial processing of N-linked oligosaccharides in the rough ER of 
vertebrate cells and decision of further transport to the Golgi network by the ER quality 
control. The Glc3Man9GlcNAc2 precursor is transferred from the dolichol carrier to a susceptible 
Asn residue on a nascent protein as soon as the asparagine crosses to the luminal side of the ER 
(step 1). In three separate reactions, one glucose residue (step 2), then two glucose residues (step 
3), and finally one mannose residue (step 4) are removed. Re-addition of one glucose residue (step 
3a) is part of the ER quality control process. Following these reactions, the newly made protein is 
transported in a vesicle to the Golgi network for further processing of the glycans resulting in more 
complex oligosaccharide structures.  
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between the glycoproteins and classical ER chaperones (e.g. Bip) and other 
folding assistant proteins. At the same time CNX retains unfolded or misfolded 
glycoproteins within the ER (Ou et al., 1993; Sousa et al., 1992; Chen et al., 1995; 
for reviews see: Trombetta and Helenius, 1998; Chevet et al, 1999; Parodi, 2000 
a, b). In addition to CNX, other chaperones are involved in the retention of 
misfolded proteins, such as BiP (Bonnerot et al., 1994) and GRP94 (Melnick et al, 
1992). 
Cells respond to accumulation of unfolded proteins in the rough ER, e.g. by 
elevating the transcription of sets of target genes or by slowing general translation. 
This reaction to ER stress is known as the 'unfolded protein response' (UPR). As 
sensors for misfolded proteins, several transmembrane kinases are suggested 
(e.g.: PERK /PEK (Silverman and Williams, 1999; Shi et al., 1998); Ire1p and 
Ern1p (Shamu and Walter, 1996; Shamu, 1998; Tirasophon et al, 1998; Okamara 
et al., 2000)), which communicate the ER stress to the cytosol. Signal transduction 
mechanisms finally induce the transcription of genes with an UPR promoter 
element, found for diverse genes, including chaperones and components of the 
quality control but also elements of the apoptotic machinery. Therefore, the UPR 
might function to increase the probability of correct folding as well as the ability to 
retain and degrade misfolded proteins or to induce cell death after long-term 
stress. These tasks are important for the cell, since a failure of correct folding of 
proteins not only disturbs the ER function but also exposes the cell to the potential 
toxic effect of unfolded proteins. (for review: Patil and Walter, 2001; Chevet et al., 
1999; Imaizumi et al., 2001). 
 
4 L1∆hbs and L1C264Y are retained in the ER 
The occurrence of L1∆hbs and L1C264Y protein with a reduced molecular 
weight of 190 kD suggested differences in the glycosylation state when compared 
to L1wt. Indeed, L1∆hbs and L1C264Y protein was sensitive to endo H digestion, 
an enzyme which cleaves N-glycans with terminal mannose residues. Since such 
glycans are characteristic for glycoproteins within the ER and early Golgi 
compartments, and since the ER is the ´checkpoint` for further transport to the 
Golgi network, whereas the glycans of glycoproteins are rapidly further modified in 
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the Golgi network, it is evident that L1∆hbs and L1C264Y are retained within the 
ER most likely because of a misfolding of the mutated proteins. Such a misfolding 
is conceivable in the case of L1C264Y due to the fact that the substituted cysteine 
residue is essential for the formation of a disulfide bridge in the third Ig-like domain 
of L1. The amino acid Arg at position 184 which is affected by the 14 amino acid 
deletion of L1∆hbs is suggested to be a key residue, affecting the structure of the 
corresponding Ig domain in L1 (Bateman et al., 1996). Therefore, it is likely that 
the proposed structural changes might lead to ER retention. Two pathogenic 
missense mutations of the Arg-184 residues, R184Q and R184W, cause indeed 
severe phenotypes in humans (Jouet et al., 1994; Fransen et al., 1996). 
An intracellularly located 190 kD protein in addition to a full length cell surface 
expressed 200 kD protein form was also found in lysates of cells transfected with 
L1wt, sL1 or L1ex. This finding was also observed in other studies (e.g. Moulding 
et al., 2000) and might be related to artificial effects of the cell culture system. The 
above-mentioned expression of high levels of highly glycosylated L1 (putatively 21 
N-glycosylation sites) might overstrain the postranslational processing machinery 
of the ER. Therefore, part of the L1 protein is not yet surface-expressed rather 
than permanently retained in the ER. Similarly, in CHO cells transfected with N-
CAM (containing 6 N-glycosylation sites), also significant amounts of the N-CAM 
protein was endo H-sensitive. In comparison to L1-transfected CHO cells, the 
amount of endo H-sensitive N-CAM protein in relation to the cell surface 
expressed protein was lower (Markus Delling, ZMNH, personal communication). In 
addition, mice which overexpress L1 in neurons (transgenic expression of L1 
under the control of the Thy-1 promoter; about 200-300 % of L1 levels found in wt 
mice) a significant amount of L1 is present as an endo H-sensitive 190 kD protein 
(Meike Zerwas, ZMNH, personal communication). 
 
5 Studies on L1 extracellular missense mutations 
The extracellular pathogenic L1 missense mutations R184Q and D598N have 
recently been studied in vitro and reported to be expressed at only very low levels 
at the cell surface and to be incompletely processed for up to 24 hours after 
infection (Moulding et al., 2000). In addition, variable degrees of reduced cell 
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surface expression have recently been demonstrated for a variety of extracellular 
missense mutations, including R184Q and C264Y, whereas the D598N mutation 
was shown to be expressed at the cell surface (De Angelis et al., 2002). Low 
levels of cell surface expression of mutated L1 proteins detected in these studies 
are in line with our observation of weak cell surface expression of L1∆hbs and 
L1C264Y in short-term, transient transfection experiments. However, this weak 
cell surface expression disappeared after prolonged culture periods. We suggest 
that the early cell surface expression of L1∆hbs and L1C264Y is the result of an 
ineffective retention of misfolded proteins within the ER at initial stages of 
expression, rather than a targeting of the 190 kD form of L1 to the cell surface (as 
supposed by Moulding et al., 2000). Indeed, biotinylation experiments with live 
cells revealed labeling of the 220 kD form of L1 and its proteolytic cleavage 
fragments, but not of the 190 kD form. An initially ineffective ER retention of 
misfolded protein might be likely for cell culture systems in which high levels of 
protein are expressed from the introduced DNA (driven by a constitutive CMV 
promoter). Since accumulation of misfolded proteins triggers an UPR in the ER 
which subsequently initiates increased expression of chaperones and components 
of the ER quality control, ER retention of misfolded proteins might become more 
effective after prolonged time periods in culture. 
The recently published report of apparent cell surface expression of the 
missense mutation R184Q in HEK 293 cells (Needham et al., 2001) is probably 
explained by the use of paraformaldehyde-fixed cells for immunocytochemical 
analysis, given that such a treatment permeabilizes cells and thus results in 
labeling of intracellularly located L1 protein (Moulding et al., 2000; the present 
study). Indeed, in a previous study five missense mutations, including R184Q and 
C264Y, were proposed to be cell surface expressed based on 
immunocytochemistry of paraformaldehyde-fixed cells (De Angelis et al., 1999). 
Amendatory, these L1 mutations were later demonstrated to be intracellularly 
located (De Angelis et al., 2001). 
The combined in vitro observations of the present and previous studies (De 
Angelis et al., 2002) demonstrate that mutations in the extracellular domain of L1 
interfere with the targeting of the protein to the cell surface, suggesting that many 
mutations in the extracellular domain of L1 might correspond to loss of function 
mutations. 
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6 Mutations of the intracellular domain 
In contrast to mutations in the extracellular domain, L1ex, which lacks most of 
the intracellular domain of L1, is expressed at similarly high levels at the cell 
surface as L1wt. Strong cell surface expression has also been reported for the 
intracellularly located pathogenic mutation S1194L (Moulding et al., 2000). Based 
on these findings, we hypothesize that the intracellular domain of L1 is unlikely to 
be important for correct folding of the protein, i.e. it is not subject of the quality 
control within the ER. However, pathogenic mutations in the intracellular domain 
might affect one or more functions of this domain, e.g. interactions with the 
skeleton or signal transduction cascades. For example, the two missense 
mutations (S1224L (the contribution of this Ser residue to ankyrin was previously 
unknown), and Y1229H) which alter amino acids within or nascent to the ankyrin 
binding motif (Fig. 4) were shown to reduce the ability of L1 to recruit ankyrin to 
the plasma membrane; the mutation S1224L was additionally shown to enhance 
clatherin-dependent endocytosis (Needham et al., 2001). 
 
7 The L1C264Y-transgenic mouse 
To evaluate whether an intracellular retention of L1C264Y indeed causes loss 
of L1 function and therefore lead to the severe clinical picture of patients carrying 
this mutation (Jouet et al., 1993), we generated a transgenic mouse line 
expressing L1C264Y under regulatory elements of the L1 gene (Kallunki et al., 
1998). The transgenic animals were crossed into a L1-deficient background 
(Dahme et al., 1997; Rolf et al., 2001) to study expression of the transgene and its 
effects on the development of the nervous system. The spatial and temporal 
expression of L1C264Y was comparable to L1 expression in wt mice. However, 
we found an exclusive expression of a 190 kD form of L1 which lacks Golgi-type 
sugar processing by immunoblot analysis, and an intracellular localization of the 
L1 protein by immunohistochemistry, in line with our observations in vitro. Thus, 
L1C264Y transgenic mice are likely to represent functional null mutants. Analysis 
of transgenic mice and L1-deficient animals indeed revealed similar phenotypes of 
both mutant mouse lines. Both, L1C264Y transgenic and L1-deficient animals 
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were smaller in size, exhibited increased mortality, displayed hypoplasia of the 
CST and pathfinding errors of corticospinal axons at the pyramidal decussation, 
and showed impaired interactions between nonmyelinating Schwann cells and 
axons in peripheral nerves (Dahme et al., 1997; Cohen et al., 1998; Haney et al., 
1999).  
 
8 The fate of intracellularly retained misfolded protein 
The similar pathology of L1C264Y transgenic and L1-deficient mice allows 
speculations about the fate of intracellularly located L1 mutant protein. For a 
detailed discussion a general overview of the molecular consequences of 
mutations is given. Missense mutations and short deletions and insertions can be 
divided into two groups with respect to their molecular consequences at the 
protein level: 1) mutations affecting functional sites, which are characterized by the 
presence of normal amounts of protein at the correct place, but impaired functional 
activity (Fig. 29-1), and 2) mutations that decrease or abolish the level of mutant 
protein at their designated cellular location (Fig. 29-2A/B; Bross et al., 1999). 
Frequent causes for the second group of mutations are disturbances of the folding 
process of proteins. Diseases which are linked to these molecular mechanisms 
are termed conformational or protein folding diseases (Thomas et al., 1995; 
Beissinger and Buchner, 1998), and two subgroups are distinguishable.  
In the first subgroup aberrant folded proteins form insoluble aggregates and 
thus can not be translocated into transport vesicles or into the cytosol for 
degradation (Fig. 29-2A; see below; Pfeffer and Rothman, 1987). Ongoing 
accumulation of undegraded, misfolded proteins in the ER, triggers the UPR and is 
likely to clog the secretory pathway and to become toxic to the cells (Kaufman, 
1999; Klausner and Sita,1990: Stevens and Argon, 1999). For example, in special 
forms of α1-antitrypsin deficiency (about 10-15 % of all α1-antitrypsin deficiency 
causing mutations), missense mutations in the gene encoding α1-antitrypsin lead 
to the formation of crystalline-like aggregates that are not exported from the ER. 
As a result, the secretion of other proteins is also impaired, ultimately leading to 
cell death (Carlson et al., 1989; Lomas et al., 1992; Lomas, 1996). Therefore, 
patients with such mutations develop liver diseases in addition to emphysema, the 
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general syndrome of α1-antitrypsin deficiency (Perlmutter, 1998; Wu et al., 1994). 
Similarly, cell toxic effects have been found for mutated and misfolded PLP 
(proteolipid protein; Jung et al., 1996). Mutations in the PLP gene result in severe 
dysmyelination of the CNS of jimpy mice or cause Pelizaeus-Merzbacher disease 
in humans, largely due to the death of oligodendrocytes (Knapp et al., 1986; 
Vermeesch et al., 1990; Gencic and Hudson, 1990). With regard to the occurrence 
of cell death or impaired maturation of other proteins in the ER as a consequence 
of aggregated misfolded protein, it is evident that the underlying mutations act in a 
"dominant-negative" fashion or exhibit a combination of loss- and gain-of-function 
effects. Indeed, the phenotype of the natural occurring jimpy mouse could not be 
completely rescued by the introduction of a wild-type PLP transgene (Nadon et al., 
1994; Schneider et al., 1995). In contrast, dysmyelination was reduced to 
moderate levels when the expression of the mutated allele was down-regulated 
(Boison and Stoffel, 1994; Boison et al., 1995). 
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Figure 29: Possible fate of mutated proteins. Mutated proteins that are correctly folded are 
further transported to their destined targets (1). Misfolded proteins with folding mutations can either 
form unsoluble aggregates (2A) or become degraded (2B). 
 
The second group of conformational diseases is characterized by a rapid 
degradation of misfolded proteins (Fig. 29-2B), the so-called ER-associated 
degradation (ERAD; McCracken and Brodsky, 1996). The development of a 
system that is not only able to recognize irreversibly misfolded proteins, but to 
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target them for degradation, is an essential function for cell survival. The major 
mechanism of ERAD is the dislocation of misfolded proteins from the ER, 
presumably via reverse translocation through the ER translocon (Wiertz et al., 
1996; Plemper and Wolf, 1999) to the cytosol for selective protein degradation by 
the ubiquitin-proteasome pathway (Ciechanover, 1994; Goldberg, 1995; Jentsch; 
1995; Hiller et al., 1996). The steps involved in this process include partial 
proteolysis of the misfolded protein within the ER, ubiquitination, extraction from 
the ER, and the removal of all previously attached N-linked carbohydrates before 
complete proteasomal digestion (Kopito, 1997; Coux et al., 1996). The core 
complex of proteasomes is composed of four stacked seven-membered rings of 
subunits, which build a cylindrical structure and contain the proteolytic enzymes 
and two apertures, one at each side of the cylinder, which allow access to the 
cavity only for unfolded proteins (Groll et al., 1997). A prominent example for such 
a mechanism is cystic fibrosis, in which the most common CFTR (cystic fibrosis 
transmembrane conductance regulator) mutation (∆F508) is retained in the ER for 
longer times than the wild-type form, followed by ubiquitination and retrograde 
transport to the cytosol where it is degraded by the proteasome (Jensen et al., 
1995; Ward et al., 1995). Further examples are most forms of α1-antitrypsin 
deficiency (gene: α1-antitrypsin; Mahadeva et al., 1998), Tay-Sachs disease 
(gene: β-hexosaminidase; Lau and Neufeld, 1989), Charcot-Marie-Tooth (gene: 
connexin 32; Deschenes et al., 1997; Bone et al., 1997), familial 
hypercholesterolemia (gene: LDL receptor; Hobbs et al., 1990), and retinitis 
pigmentosa (gene: rhodopsin; Olsson et al, 1992). In general, rapid ERAD of the 
mutated and misfolded protein leads to loss of function of the affected protein.  
The L1C264Y transgenic mouse line expresses about 30 % of the amount of L1 
protein found in wt mice. This is the highest amount found in five founder lines. It is 
likely that this reduced amount of L1 might be due to a decreased half-life of the 
mutated L1 protein as a result of rapid degradation, which is typical for diseases 
leading to ERAD of proteins with folding mutations (Bross et al., 1999). For 
example the ∆F508 variant that causes cystic fibrosis is degraded almost to 
completion (Ward and Kopito, 1994). Therefore, the apparent amount of L1 protein 
in L1C264Y transgenic, compared to that in wt mice, allows no direct statement on 
the amount of de novo synthesized L1C264Y versus L1 wt protein. More 
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information about the expression levels of L1 in L1C264Y versus wt mice might be 
obtained from quantification of mRNA levels.  
The phenotype of L1C264Y transgenic mice is similar to that of L1-deficient 
mice. Therefore, we do not assume negative effects of intracellularly retained 
L1C264Y on cell viability or function, as seen in other diseases characterized by 
an aggregation of proteins within cells. Indeed, we have not observed any obvious 
decrease in the number of cells that normally express L1 at the cell surface in the 
L1C264Y mutant in comparison to the L1-deficient mouse. Furthermore, the area 
of the CST was not further reduced in L1C264Y in comparison to L1-/y mice. The 
cortical pyramidal neurons are likely to be affected in case of decreased cell 
viability as a result of intracellular accumulation of mutated protein, since these 
cells normally express high levels of L1 protein. In addition, we did not observed 
any abnormalities in L1+/y_C264Y mice (which express L1C264Y in addition to 
the endogenous wild-type L1) in comparison to wt mice in terms of body weight, 
survival, or size of the CST, arguing against the possibility of dominant-negative 
effects of the L1C264Y protein. We thus hypothesize that mutated L1 variants that 
are retained within the ER become degraded by proteasomes after release to the 
cytosol without exerting negative effects on cell survival or function. 
 
9 Concluding remarks and outlook 
In summary, we have confirmed and extended observations that demonstrate a 
reduction or lack of cell surface expression of mutated L1 variants in vitro 
(Moulding et al., 2000; De Angelis et al., 2002). More importantly, we have 
demonstrated for the first time that a pathogenic missense mutation of L1 results 
in lack of cell surface expression in vivo, causing a phenotype indistinguishable 
from that of the L1-deficient mouse. Other extracellular missense mutations of L1 
have been shown to be transported to the cell surface (De Angelis et al., 2001) 
affecting homophilic and/or heterophilic binding, e.g. to axonin-1/TAG-1/TAX-1 or 
contactin /F11/F3. Thus, impaired trafficking of L1 to the cell surface, in addition to 
abnormal heterophilic and homophilic interactions of mutated L1 proteins that 
reach the cell surface (De Angelis et al., 1999 and 2002), potentially explains the 
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high phenotypic variability caused by L1 mutations, particularly within the 
extracellular domain of the protein.  
Whether our results of impaired cell surface expression of the L1C264Y 
mutation and the proposed underlying mechanisms (see below) can be 
extrapolated to other L1 mutations that are not expressed at the cell surface 
remains to be investigated. Results of the present study have important 
implications for the design of such investigations in cell culture systems. A 
complete retention of mutated L1 and exclusive expression of the 190 kD protein 
in L1∆hbs- and L1C264Y-transfected cells was found only after prolonged culture 
times and thus closely resembles the in vivo findings, namely the exclusive 
occurrence of an intracellularly located 190 kD protein in L1C264Y transgenic 
mice. Therefore, prolonged times in culture might be important to make reliable 
predictions on whether a pathological missense mutation is expressed in vivo on 
the cell surface or not. Moreover, our findings suggest that the occurrence of a 190 
kD form of mutated L1 which lacks Golgi-type sugar processing is sufficient to 
predict an intracellular retention of mutated L1 variants. 
We suggest ER retention followed by ERAD as the most likely underlying 
molecular pathomechanism of the L1C264Y mutated protein, which ultimately 
results in the complete loss of L1 function. This assumption has to be verified in 
further experiments in vitro, for example by inhibition of the proteasome 
degradation pathway (e.g. with lactacystin, Novoradovskaya et al., 1998), 
estimation of degradation rates (e.g. by pulse-chase experiments), or direct 
verification or inhibition of protein binding to chaperones involved in ER retention 
(e.g. to CNX; e.g. by co-immunprecipitation). Similar investigations, particularly the 
binding/colocalization to chaperones or inhibition of supposed interactions and 
pathways can be performed in vivo using the L1C264Y transgenic mouse as a 
model system or by using primary neurons isolated from L1C264Y transgenic 
mice. Analysis of mice carrying two L1C264Y transgenic alleles in a L1-deficient 
background, and thus presumably expressing higher levels of mutated L1 protein, 
might give further insights into the fate of intracellularly located, mutated L1. 
Some of these experiments may also provide important insights into possible 
therapeutical approaches. First attempts to develop such approaches are based 
on the regulation of ER retention and degradation systems by compounds that 
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target some of its members, with the final aim to restore the transport of the 
protein to the cell surface. In several studies, rescue of the ER-sequestered 
mutant proteins was achieved using either chemical (Sato et al., 1996; 
Tamarappoo and Verkman, 1998) or specific pharmacological (Morello et al., 
2000) chaperones, or inhibitors of the degradation pathway, for example 
lactacystin, which can result in accumulation of the protein but in some cases also 
in a partial restoration of protein transport to the cell surface (Novoradovskaya et 
al., 1998). If such approaches are applicable for distinct L1 mutations depends, 
among other factors, on whether a particular mutation interferes with the normal 
function of the L1 protein. Investigations using purified mutated L1-Fc fragments 
have indeed demonstrated that many of the pathogenic L1 mutations that are now 
known not to reach the cell surface impair homophilic and/or heterophilic binding 
to TAX-1, among them R184Q and C264Y (De Angelis et al., 1999 and 2002).  
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VI Appendix 
1 Abbreviations 
µ micro (10-6) 
xg g-force 
°C grad celsius 
aa amino acid 
A adenine 
Amp ampicillin 
APS ammoniumperoxidisulfate 
bp base pairs 
BSA bovine serum albumine 
C cytosine 
cDNA complementary  
 deoxyribonucleic acid 
CHO Chinese Hamster Ovarian 
Cm chloramphenicol 
CMV cytomegalie virus 
CST corticospinal tract 
dNTP 2’-desoxyribonucleotide- 
 5’-triphosphate 
ECM  extracellular matrix 
EDTA ethylendiamintetraacetic  
 acid 
FCS fetal calf serum 
g gram 
G guanosine 
h hour(s) 
IPTG isopropyl-β-D- 
 thiogalactoside 
Kan kanamycin 
kb kilo base pairs 
l liter 
LB Luria Bertani 
m milli (10-3) 
MEM minimal essential medium 
min  minute 
MOPS (4-(N-morpholino)-propan)- 
 sulfonic acid 
mRNA messenger ribonucleic acid 
n nano (10-9) 
OD optic density 
p pico (10-12) 
PAGE polyacrylamide gel  
 electrophoresis 
PBS phosphat buffer 
PCR polymerase chain reaction 
rpm rounds per minute 
RNA ribonucleic acid 
RT room temperature 
SDS sodium dodecyl sulfate 
T thymin 
TEMED  N,N,N’,N’-
tetraethylenamine 
Tm melting temperature 
Tris tris(-hydroxymethyl)- 
 aminomethane 
U unit (enzymaticP 
V volt 
vol volume 
v/v volume per volume 
w/v veight per volume 
Amino acids were abbreviated using the one letter code 
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2 Oligonucleotides 
2.1 Primer for sequencing of mouse L1 cDNA 
Start and end bp indicate the position of the primers on the EcoRI-fragment with 
L1cDNA of the pGEM2-L1 plasmid. 
 
name start bp end bp sequence 
Forward primer   
L1X1 44 64 5´-TGA TGC TGC GGT ACG TGT GGC-3´ 
DEIa1 444 463 5´-GTG GCC GAA GGA GAC TGT AA-3´ 
DEIa2 484 503 5´-GGA GAA TCA GTA GTT CTG CC-3´ 
L1B1 501 528 5´-GCC TTG CAA CCC TCC ACC CAG TGC AGC C-3´ 
DEIIa 933 952 5´-CAA TGT GGG CGA AGA GGA CG-3´ 
L1B2 976 1000 5´-GAG AAC TCG CTG GGC AGT GCC CGG C-3´ 
DEIIIa 1407 1427 5´-CCA GTG GCT GGA TGA AGA AGG-3´ 
L1B3 1494 1515 5´-CCA GGC CAA TGA CAC TGG ACG C-3´ 
DEIVa 1945 1965 5´-GCT GAA GAC CAC AAC TCT CCC-3´ 
L15´.2 2253 2285 5´-GAT GGA TTG GAA TGC CCC CCA GAT TCA GTA CCG-3´ 
Apa 1 2355 2381 5´-GGT GTC TAA CAC TTC CAC ATT TGT GCC-3´ 
Seq 1 2485 2505 5´-CTT GAA GAC ATC ACA ATC TTC-3´ 
Apa 2 2835 2863 5´-GCT ACT GCA CTG GCA GCC ACC ACT CAG CC-3´ 
Apa 3.2 3336 3365 5´-CCA TCT GGA TGT GAA GAC TAA TGG-3´ 
L13´dn 3781 3811 5´-GCT ACC TCT CCT ATC AAT CCT GCA GTA GCC C-3´ 
Reward primer   
L1 5´up 112 80 5´-ATT CGT CTG GAA TCT GTA TGA GCA GGC AGG GGC-3´ 
L1X4 291 268 5´-CAC TAC ACC CAA TTC TTC CTT GGG-3´ 
DEIVb 2488 2469 5´-CAA GTT CAG GGC TCA CCT GG-3´ 
Seq 2 2892 2872 5´-GAG CAG GTA GCC AGT GAG CAC-3´ 
DEIIb 3055 3036 5´-CTG GCT TGC CAA ACA GGG CC-3´ 
DEIb2 3482 3501 5´-TGA GTA TTT GCC ACC CTT GC-3´ 
DEIb1 3498 3517 5´-CCT CCT TGT CCT TCA CTG AG-3´ 
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2.2 Primer for sequencing of transgenic construct 
After cloning the transgenic construct, the borders between L1 promoter, 
mL1cDNA, and NRSE sequence were controlled by sequencing.  
 
PL1.1 5´-gtg gcc acc acc aaa atc aag c-3´ 
PL1.2 5´-cag gag ggt agt gga atc tgg c-3´ 
Amp-down 5´-atg ttg aat act cat act ctt-3´ 
PL1-up 5´-tat cca ctc cct tca tac tct-3´ 
gal-up 5´-aag atc gca ctc cag cca gct-3´ 
NRSE1 5´-agt gct ctt cag tta ctc ac-3´ 
 
2.3 Primer for genotyping 
L1-A´  5´-tgg gaa gac aat agc agg cat-3´ 
L1-C 5´-ggt agg cag gag ata agg tca-3´ 
L1-D 5´-cag tca ttg atc ctg gag tgc-3´ 
L1-ki 5´-tcg cga tga ctt agt aaa gca cat-3´ 
L1-5´up2 5´-aga ggc cac acg tac cgc agc atc-3´ 
tTa-up3 5´-tac atg cca ata caa tgt agg ctg c-3´ 
L1arm 5´att gtt gat gct gca gat gca gct g-3´ 
L1-292 5´-gca ccc tat tct ggc tcc tt-3´ 
L1-709 5´-atg ctg ttg gtg ggc ttg ac-3´ 
 
2.4 Primer for PCR mutagenesis  
DE2-A 5´-catg ctcttc attgctagagccacctgtcatcac-3´ 
DE2-B 5´-acgt ctcttc acaattcgtctggaatctgtatgagc-3´ 
DE27-A 5´-catg ctcttc cacagtgacaatgaagagaaggcctt-3´ 
DE27-B 5´-acgt ctcttc actgtactcgccgaaggtctcgtct-3´ 
Dhbs-A 5´-catg ctcttc aggacctatattttgccaatgtgc-3´ 
Dhbs-B 5´-acgt ctcttc atccaaaatcttgctgttcatccag-3´ 
SCY-A 5´-catg ctcttc atacattgctgagggattcccta-3´ 
SCY-B 5´-acgt ctcttc agtactccaggatcaatgactggc-3´ 
Bold letters indicate the Eam1104I-restriction side. 
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3 Mutations in the of L1cDNA  
For cell culture investigations and generation of a transgenic mouse line different 
mutated L1cDNAs were created by PCR mutagenesis. The indicated nucleotide 
and amino acid (aa) position are in relation to the mouse L1cDNA beginning with 
ATG as nucleotide position1. 
 
L1∆E2 – deletion of exon 2 
In L1∆E2 the nucleotides 77 – 91  were deleted (red) encoding aa 26 – 31 which 
comprises exon 2 leading to a single leucine blue residue in place of six amino 
acids, using the primers DE2-A and -B. Above the original, below the mutated 
DNA and aa sequences are shown. 
 
20             25             30             35
I  Q  I  P  D  E    L  E  P  P  V  I  T
ATACAGATTCCAGACGAA CTAGAGCCACCTGTCATCACG
  60               
Y
T TG
  K  G  H  H  V
ATAAAGGACACCATG
77            91
I  Q  I  P  D  E    L  E  P  P  V  I  T
ATACAGATTCCAGACGAA CTAGAGCCACCTGTCATCACG
L
TTG  
 
L1∆E27 – deletion of exon 27 
In L1∆E27 the nucleotides 3540 –  3551 were deleted (red) encoding aa 1180 – 
1183 which comprises exon 27 by usage of primers DE27-A and -B. Above the 
original, below the mutated DNA and aa sequences are shown. 
 
   1175           1180           1185           1190 
E  T  F  G  E  Y      D  N  E  E  K  A  F
GAGACCTTCGGCGAGTAC GACAATGAAGAGAAGGCCTTT
3520                       
R  S  L  E
GTCCCTGGAGAG
3540 3551
S
AG T
 
E  T  F  G  E  Y    D  N  E  E  K  A  F
GAGACCTTCGGCGAGTAC GACAATGAAGAGAAGGCCTTT
S
AGT  
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L1ex – the extracellular domain of L1 
L1ex comprise the whole extracellular (blue) and transmembrane part (orange), 
and the first nine amino acids of the intracellular domain (green; remains aa 1 – 
1152 of L1cDNA) in fusion with a HA-tag (violet; cloned by P. Kallunki). 
 
3398 catctggatg tgaagactaa tggaactggc cctgtgcgag tttctactac 
1100 H  L  D  V   K  T  N   G  T  G   P  V  R  V   S  T  T  
3348 agggagcttt gcctccgagg gctggttcat cgcctttgtc agcgctatca  
1117  A  S  E   G  W  F  I   A  F  V   S  A  I   I  L  L  L  
3398 ttctcttgct cctcatcctg ctcatcctct gcttcatcaa acgcagcaag  
1134   L  I  G   S  F  L   L  I  L  C   F  I  K   R  S  K   
3448 ggcggcccta tgatcccata cgatgttcca gattacgcct ag 
1151 G  G  P  M   I  P  Y   D  V  P   D  Y  A  - 
 
L1∆hbs – deletion of the putative homophilic binding site 
In L1∆hbs the nucleotices 529–570 were deleted encoding for the putative 
homophilic binding site of L1 (Zhao et al., 1998) unsing primers Dhbs-A and -B. 
Above the original, below the mutated DNA and aa sequences are shown. 
 
174      177                                    190
K  I  F    D  L  Y 
AAGATTTTG GACCTATAT
520      
H  I  K  Q  D  E  R  V  S  M  G  Q  N  G
CACATCAAACAAGATGAGCGGGTGTCCATGGGCCAGAATGGA
529                                      570
K  I  F   D  L  Y 
AAGATTTTG GACCTATAT  
 
L1C264Y – missense mutation  
In L1C264Y a guanin at nucleotide position 788 (red) was replaced by an adenin 
leading to an exchange of Cys to Tyr at aa 263 (corresponding to nucleotide 264 
in human L1)The primers SCY-A and -B were used. Above the original, below the 
mutated DNA and aa sequences are shown. 
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               263
S  L  I  L  G    I  A  G  G  F
TCATTGATCCTGGAG ATTGCTGAGGGATTC
                788
C
GT C
S  L  I  L  G    I  A  G  G  F
TCATTGATCCTGGAG ATTGCTGAGGGATTC
Y
AT C  
 
4 L1 plasmids 
4.1 Cloning of mutated L1cDNAs into a mammalian expression 
vector 
Different mutated L1cDNAs were created by PCR mutagenesis using the vector 
pGEM2-L1wt was differently mutated via PCR. Subsequently, the mutated 
L1cDNAs were cloned into the cloning vector pK19 (derived from the pUC19 
vector by replacing the Amp- with an Kann-resistence gene) and further cloned 
into the pcDNA3 expression vector, each time using the EcoRI restriction sites. 
mL1 indicates all mutated L1 constructs (L1∆E2, L1∆E27, sL1, L1∆hbs, L1C264Y, 
L1wt). 
 
pGEM2-L1
6931 bp
mL1
lac-op
Amp r
T7 P
SP6 P
BamHI (2751)
BamHI (4081)
EcoRI (1)
EcoRI (4063)
NcoI (996)
NcoI (3474)
PstI (268)
PstI (3029)
PstI (3993)
PstI (4103)
ApaLI (157)
ApaLI (2140)ApaLI (4645)
ApaLI (5891)
ApaLI (6388)
 
AvaI (4076)
HindIII (4108)
Sma I (4078)
XmaI (4076)
 
VI Appendix     115 
 
 
 
pcDNA3-L1
9508 bp
mL1
Amp r
BGHpA
pCMV
pSV40
neo
HindIII (890)
SmaI (6155)
XmaI (6153)
AvaI (5034)
AvaI (6153)
BamHI (908)
BamHI (2251)
EcoRI (939)
EcoRI (5001)
ApaLI (2862)
ApaLI (4845)
ApaLI (8007)
ApaLI (9253) NcoI (611)
NcoI (1528)
NcoI (4006)
NcoI (6039)
NcoI (6774)
PstI (1017)
PstI (1981)
PstI (4742)PstI (5010)
PstI (6395)
 
 
 
4.2 Cloning of the L1C264Y transgenic construct 
An EcoRI-PvuI-fragment of pcDNA3-L1C264Y was initially cloned into the EcoRI-
opened vector pBlueCAM-SK(+). The lacZ gene was removed from vector L1lacZ 
(kind gift of P. Kallunki; Kallunki et al., 1997 and 1998; Meech et al., 1997) by 
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digestion with NotI and XhoI and replaced with L1C264Y. The 22 kb-transgenic 
construct was excised from the plasmid by digestion with PvuI and SnaBI 
 
pBlueCmSK(+)-L1
7461 bp mL1
Cam r
lacZ´-2
lacZ´-1
plac
ColE1ori
BamHI (1313)
BamHI (4081)
Eco RI (1)
Eco RI (4063)
Nco I (590)
Nco I (3068)
Nco I (6000)
 
Cla I (7445)
HindIII (7450)
Sma I (4077)
Xma I (4075)
Not I (4100)
Xho I (7429)
ClaI (13803)
Not I (17919)
SnaBI (21893)
Xho I (13787)
pPL1-L1
24543 bp
mL1
Ampr
SV40pA
L1-promoter
NRSE
XmaI (14)
XmaI (17894)
Pvu I (23532)
Pvu I (24428)
Sma I (16)
Sma I (17896)
XmnI (15836)
XmnI (18697)
XmnI (20716)
XmnI (23761)
HindIII (142)
HindIII (1663)
HindIII (2208)
HindIII (7161)
HindIII (13808)
HindIII (18683)
HindIII (20241)
HindIII (21910)
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